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ABSTRACT: 
Characterization of the genetic diversity and antimicrobial resistance in 
Mannheimia haemolytica from feedlot cattle 
 
Mannheimia haemolytica is an opportunistic pathogen in cattle and the main 
bacterial agent in bovine respiratory disease.  Despite its economic importance, few 
studies have characterized the genetic diversity of M. haemolytica, particularly from 
feedlots.  Three genotyping techniques (BOX-PCR, (GTG)5-PCR and PFGE) were 
compared to discriminate M. haemolytica and strains from the family Pasteurellaceae.  
PFGE was the most discriminating and repeatable, although BOX-PCR was most 
accurate in clustering isolates together according to species. 
  Mannheimia haemolytica was isolated from nasal swab samples collected from 
cattle upon entry and exit from two feedlots in southern Alberta.  These were 
characterized by PFGE and antimicrobial susceptibility using a disk-diffusion assay.  
Select gene determinants were screened for using PCR.  PFGE analysis revealed the 
isolates to be highly diverse.  Ten percent of the isolates exhibited resistance.  At present, 
the development and spread of antimicrobial resistance in M. haemolytica observed 
within the feedlots examined appears to be low.   
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CHAPTER ONE  
 
Introduction 
 
Bovine respiratory disease (BRD) is currently one of the most economically 
important health problems for cattle producers.  Financial losses due to the condition 
exceeded the combined costs of all other diseases of cattle (Highlander, 2001) and are 
incurred through treatment cost, production loss and death.  Control strategies for this 
disease are limited to feed management and treatment with vaccines and antimicrobials.  
The latter has lead to concerns regarding the development and spread of antimicrobial 
resistance.  Many viral and bacterial agents contribute to the BRD complex, but 
Mannheimia haemolytica is identified as the primary bacterial pathogen.  Development of 
antimicrobial resistance in this pathogen holds consequence for maintaining efficacy of 
antimicrobial therapies and management of the disease.  
 
1.1 Bovine respiratory disease 
1.1.1 Economics and prevalence  
In terms of economics, BRD is the most important disease affecting feedlot cattle 
throughout North America (Gardner et al., 1999; Griffin, 1997).  It is the primary cause 
for loss associated with sickness and death (Gagea et al., 2006; Larson, 2005) and is 
estimated to be responsible for up to 75% of morbidity and up to 70% of mortality in 
received cattle (Edwards, 1996; Encinias et al., 2006).  Mean monthly mortality rates 
have been shown to range from 0.128% (Vogel and Parrott, 1994) to 0.71% of occupancy 
(Edwards, 1996), however, prevalence is reported to be variable based upon both 
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geography (Gagea et al., 2006) and season (Vogel and Parrott, 1994).  In the USA, death 
losses due to BRD were observed to have increased between 1994 and 1999 with an 
average incidence rate of 1.42% documented from the twelve states surveyed in 1999 
(Dedonder, 2008; Snowder et al., 2006).  Further extension of this study revealed that this 
rate reached 1.75% in 2003 (Thomson and White, 2006).    
An accurate evaluation of the exact economic losses accountable to BRD is 
difficult to find.  Estimates within the USA place the value between 640 million and 1 
billion US dollars annually (Babcock et al., 2008; Bowland and Shewen, 2000; Snowder 
et al., 2007) although factoring in treatment costs, which vary from $13.90 to $37.90 per 
head (Sanderson et al., 2008; Smith, 1998; Snowder et al., 2006), can inflate that value to 
3 billion US dollars annually (Snowder et al., 2007).  Despite the enormity of these 
numbers they are in all likelihood an underestimation of the true cost of BRD to the 
industry.  These values are primarily based upon treatment costs and death losses which 
are routinely monitored. However, there are additional losses associated with BRD that 
are not as easily determined including those attributed to increased labor expenditures, 
performance losses and reduction in carcass value (Bateman et al., 1990; Encinias et al., 
2006; Gagea et al., 2006; Larson, 2005) 
1.1.2 History and definition 
Documenting the history of BRD is a difficult task.  This is mostly due to the state 
of progression of both the knowledge base and nomenclature surrounding the condition.  
Yates (1982) has argued that the lack of a clear, workable definition for the condition has 
allowed etiological theories and vague generalizations to affect the nomenclature 
describing it, ultimately, hindering the chronological advancement of knowledge.  The 
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result of this has been an amassing of data and various terminologies that have focused 
primarily on the etiology of the condition resulting in a description rather than diagnosis 
of the condition.  This is still a large concern as a variety of terms and definitions are 
present in the literature.  In order to proceed in good standing the following section has 
been created to present a clear working definition of BRD for use within the context of 
this document, to provide a brief account of the history behind the condition and to 
clarify the various terminologies that may be encountered in current literature.   
1.1.3 Bovine respiratory disease complex vs. bovine respiratory disease 
 
The term bovine respiratory disease (BRD) complex was originally applied as an 
expansive term to describe three disease conditions that are responsible for pneumonia in 
cattle; enzootic pneumonia of calves, shipping fever complex and atypical interstitial 
pneumonia (Lillie, 1974).  Although this definition is still used on occasion (Bowland 
and Shewen, 2000), it is becoming more common to see the term BRD complex used 
exclusively with the term shipping fever (Booker et al., 2008; Gardner et al., 1999; 
Schunicht et al., 2007; Wildman et al., 2008).  This situation has in all likelihood been 
induced and perpetuated by the similarity of the term BRD complex to the term BRD, 
which is a name that is conventionally used as a synonym for shipping fever (Apley, 
2006; Larson, 2005).  As it is a potential point of confusion, any reference to the term 
BRD within this document is meant to be in association with the condition and ailments 
of shipping fever and should not be confused with the term BRD complex of which it 
should be considered a component.   
 It has recently been argued that acute interstitial pneumonia (AIP) is a syndrome 
that is not linked to the characteristic respiratory disease pathogens and as such should be 
  4 
considered a separate disease entity from the BRD complex (Woolums et al., 2005).  
Consequently, it may be more accurate to define BRD complex as a term encompassing 
the entities of enzootic pneumonia in calves and shipping fever alone. However, for the 
sake of simplicity, the working definition for BRD complex applied in the present paper 
will be held in accord with that previously outlined by Lillie (1974).   
1.1.4 History of shipping fever and current terminology 
 
  The term ‘shipping fever’ has been in use for over six hundred years, and was 
initially used to describe a variety of sicknesses in horses ranging from influenza to pink 
eye to pneumonia (Rehmtulla and Thomson, 1981).  With the turn of the 19th century, 
shipping fever became recognized as a complex of three different conditions; strangles, 
influenza and contagious pneumonia (Rehmtulla and Thomson, 1981), but it wasn’t until 
the 1950s that the term was used to describe fever and pneumonia in cattle following 
transport to feedlots (Adams et al., 1959; Graham, 1953; Ryff and Glenn, 1957).  
Association of this term with cattle generated confusion, causing both the vernacular and 
description of symptoms surrounding the disease to be varied (Rehmtulla and Thomson, 
1981).  Some of the various terms documented include transit fever, stockyard’s 
pneumonia, exposure disease, transport fever, hemorrhagic septicemia (now reserved for 
systemic infections), fibrinous pneumonia, and exposure disease (Rehmtulla and 
Thomson, 1981; Yates, 1982).   
In the 1970’s it became clear that Pasteurella spp. were a key component of the 
condition.  This led to a general acceptance of the term bovine pneumonic pasteurellosis 
(Yates, 1982) which has since been modified to bovine pneumonic mannheimiosis to 
reflect the taxonomic amendments made to the Pasteurella genus in 1999 (Angen et al., 
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1999).  Although recognized, this term is employed less commonly in publications than 
the terms shipping fever or BRD.  This is in all probability due to the complex etiology of 
the condition (discussed below) which has made it difficult for many to justify naming 
the condition after one causative agent (Yates, 1982).    
As a result of the discord over nomenclature, there is presently an array of terms 
used to discuss shipping fever/BRD.  Included are; bovine respiratory disease (BRD) 
(Apley, 2006; Larson, 2005), undifferentiated bovine respiratory disease (UBRD) 
(Bateman et al., 1990), undifferentiated fever (UF) and/or bovine respiratory disease 
(BRD) complex (Booker et al., 2008; Schunicht et al., 2007; Wildman et al., 2008), 
shipping fever and bovine pneumonic mannheimiosis.  For the purposes of this 
document, the terms BRD, shipping fever and bovine pneumonic mannheimiosis will be 
used synonymously. 
1.1.5 Symptoms and etiology 
 
The etiology of BRD is complex.  When described in general terms, BRD is 
created by a suite of environmental stressors, typically associated with transport and 
marketing, that combined are sufficient to compromise the host immune system and 
allow for pulmonary invasion by viral and/or bacterial pathogens that are ubiquitous 
within the feedlot environment (Cusack et al., 2003).  In most cases the disease is 
characterized by a primary viral infection, followed by a secondary bacterial infection, 
the agent of which ultimately colonizes the lower respiratory tract of the animal and 
causes severe fibrinonecrotic pneumonia (Kehrenberg et al., 2001b; Whiteley et al., 
1992).  Consequently, transient illness, progression to chronic pneumonia or death of the 
animal ensues (Welsh et al., 2004).    
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 Calves are most often affected by pneumonia shortly after arrival in feedlots 
(Gagea et al., 2006; Rice et al., 2007).  Acute outbreaks resulting in death last 
approximately 2 to 3 days although those that survive this period can become chronically 
ill (Mohamed and Abdelsalam, 2008). Clinical symptoms can include fever, nasal or 
ocular discharge, cough and respiratory distress, depression, lethargy, along with loss of 
both weight and appetite (Duff and Galyean, 2007; Friend et al., 1977).  The main cause 
of death is acute fibrinous pleuropneumonia (Confer et al., 1988; Rice et al., 2007) also 
termed multifactorial fibrinonecrotizing pneumonia (Highlander et al., 2000; Jeyaseelan 
et al., 2002; Whiteley et al., 1992) or bovine pneumonic mannheimiosis when associated 
with M. haemolytica.  The duration, distribution and severity of infection is unequal 
between populations (Bateman et al., 1990) and potential risk factors for the condition 
can include age, body weight, procurement method, amount of commingling before and 
after arrival, and previous vaccinations (Wildman et al., 2008).  Typically, the condition 
is centered within pens and does not sweep through the entire feedlot (Rice et al., 2007).    
Despite advancements in our understanding of BRD, the intricacies of the disease 
are still disputed and the precise contributions of each agent involved are unclear.  There 
are multiple environmental stressors that contribute to the condition and an array of 
infectious organisms, both viral and bacterial, that have been recovered from pneumonic 
animals.  The following section provides a brief description of some of the key factors 
that are associated with or contribute to the condition of BRD.  However, the focus of this 
review is of the role of one of the primary bacterial pathogens associated with the 
condition, M. haemolytica, and the remainder of the document will focus its involvement 
with BRD.        
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1.1.6 Environmental/ host factors 
 
Environmental stressors play a key role in predisposing cattle to BRD.  It is 
commonly accepted that stress negatively impacts the immune system (Duff and 
Galyean, 2007) which can lead to a propensity for viral/bacterial infection.  Cattle 
experience various stressors as they are transitioned into the feed yard.  Typically these 
are linked to transport and marketing, however, feedlot management practices may also 
play a role.  Stressors can be either psychological or physical in nature.  Psychological 
stressors are largely a result of handling technique but may also be linked to the effects of 
commingling, movement through marketing channels, weaning and novelty (Bowland 
and Shewen, 2000; Thomson and White, 2006).  Physical stressors are more numerous 
and may include hunger, thirst, fatigue, injury, thermal extremes, crowding, poor 
ventilation, castration, vaccinations, and horn tipping (Bowland and Shewen, 2000; Duff 
and Galyean, 2007; Thomson and White, 2006).  Stress provides the intiation of BRD by 
generating animals with compromised immune function while they are situated in an 
environment where the chance of exposure to infectious agents is high (Jericho, 1979).        
1.1.7 Viral factors 
 
Viral agents are potentiators for BRD infection.  They are immunosuppressive 
agents that act synergistically with other respiratory pathogens to permit bacterial 
colonization of the lower respiratory tract (Loneragan et al., 2005).  Multiple viral agents 
have been associated with  BRD ((Bowland and Shewen, 2000; Duff and Galyean, 2007); 
Table 1.1) but BHV-1, BRSV, BVDV and PI-3V are the key viral pathogens identified in 
the literature (Apley, 2006).  Complete details of the mechanics of viral infection are not 
within the scope of this paper, although generally speaking, these agents are linked with 
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diminished neutrophil and lymphocyte function (Brown et al., 1991; Brown and 
Ananaba, 1988; Woldehiwet and Sharma, 1992), an increase in the abundance of bacteria 
in the nasal pharynx, a decrease in ciliary activity of epithelial cells in the trachea (Rossi 
and Kiesel, 1977) and a reduction in clearance from the lung (Filion et al., 1984; Lopez et 
al., 1976).  All of these factors contribute to impairing host defences and allow the 
opportunity for bacteria to gain access to the lower respiratory tract possibly leading to 
bacterial pneumonia.   
 
Table 1.1 
Viral and bacterial agents linked to occurrence of bovine respiratory disease  
Viral Bacterial 
infectious bovine rhinotracheitisvirus (IBRV) Mannheimia haemolytica 
bovine herpesvirus (BHV-1)/(BHV-4) Pasteurella multocida 
bovine viral diarrhea virus (BVDV) Histophilus somnus 
bovine respiratory syncytial virus (BRSV) Actinomyces pyogenes 
parainfluenza-3 virus (PI-3V) Mycoplasma bovis 
malignant catarrhal fever virus Mycoplasma dispar 
bovine adenovirus Mycoplasma hyorhinis 
bovine rhinovirus Chlamydia spp 
bovine reovirus Ureaplasma diversum 
bovine calicivirus Streptococcus pneumoniae 
bovine  enteric coronavirus Stapylococcus aureus 
bovine parvovirus  
bovine enterovirus   
 
1.1.8 Bacterial factors 
 
As is the case with the viral agents, there are multiple bacterial pathogens 
associated with BRD (Table 1.1), M. haemolytica (formerly Pasteurella haemolytica), 
Pasteurella multocida, Haemophilus somnus and Mycoplasma bovis the most common 
bacterium isolated from morbid or deceased cattle (Apley, 2006; Thomson and White, 
2006).  There is still discussion concerning the significance of each of these pathogens in 
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the condition.  Perpetuating the debate is the consideration that all of these bacteria are 
ubiquitous commensals in cattle (Cusack et al., 2003) and although M. haemolytica is the 
most frequently recovered bacterial pathogen from cattle with BRD, many other species 
can perpetuate the condition (Cusack et al., 2003).  The fastidious nature of many of these 
organisms plays a large role in their detection ultimately making any argument linking 
prevalence of a pathogen to disease a difficult one (Dabo et al., 2008).   
In Europe, M. bovis is considered to be responsible for at least 25 to 33% of all 
pneumonia cases in calves presenting BRD (Gevaert, 2006).  Others feel the role of this 
organism in BRD is still unclear and argue that there is still challenge in the interpretation 
of its isolation from chronic cases (Apley, 2006).  H. somnus is also recovered less 
frequently than other organisms from post-mortem lung tissue but this finding is also 
argued to be a reflection of its fastidiousness nature (Cusack et al., 2003).  Pneumonia 
caused by H. somnus is generally more subacute or chronic than that caused by M. 
haemolytica or P. multocida  (Hodgins et al., 2002).  P. multocida and M. haemolytica 
are the most commonly recovered bacteria from cattle exhibiting BRD with the latter 
considered to be found most frequently (Cusack et al., 2003).  P. multocida is usually 
associated with subacute to chronic bronchopneumonia, rather than acute to subacute 
fibrinous pleuropneumonia (Welsh et al., 2004) and its role in the disease is more evident 
in dairy calves than feedlot cattle (Dabo et al., 2008).  It is considered less virulent than 
M. haemolytica as more cells are required to induce primary pneumonia in experimental 
challenge studies (Hodgins et al., 2002).   
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1.2 Mannheimia haemolytica  
1.2.1 M. haemolytica the organism 
 
Presently, M. haemolytica is considered to be the primary bacterial pathogen 
associated with shipping fever (Gioia et al., 2006; Katsuda et al., 2007; Rice et al., 2007; 
Welsh et al., 2004; Whiteley et al., 1992; Zecchinon et al., 2005).  This is because it is the 
bacterium most frequently recovered from cattle exhibiting BRD, can be isolated in pure 
culture from pneumonic lungs and can reproduce the pneumonic lesions characteristic of 
the BRD through endobronchial, intratracheal or intrapulmonary inoculation with 
serotype A1 of the bacterium (Jeyaseelan et al., 2002).  Although M. haemolytica is 
considered to be a primary pathogen in BRD it is important to reaffirm that the condition 
is a complex of factors and as this document switches its focuses to M. haemolytica it is 
important to be reminded that it is only one of the many factors involved.   
M. haemolytica is classified as a Gram-negative, non-motile, non-spore forming, 
fermentative, oxidase-positive, facultative anaerobic coccobacillus (Rice et al., 2007).  Its 
complete taxonomy is: domain Bacteria; phylum Proteobacteria; class 
Gammaproteobacteria; order Pasteurellales; family Pasteurellaceae; genus Mannheimia 
(Zecchinon et al., 2005).  It is typically found in association with ruminants (Angen et al., 
1999) and is often a commensal organism in the upper respiratory tract of healthy cattle 
(Catry et al., 2005; Lillie, 1974).  However, when an animal’s immune system becomes 
compromised the organism has shown the ability to shift to a pathogenic state, infect the 
lower respiratory tract and induce acute fibrinonecrotizing pleuropneumonia (Gioia et al., 
2006; Highlander, 2001).  This shift in pathogenicity appears to have a link with capsular 
serotype.  Serotypes A1 and A2 are the ones most commonly recovered in cattle, though 
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it is serotype A1 that is frequently found in association with pneumonic lesions 
(Dassanayake et al., 2007; Gioia et al., 2006; Katsuda et al., 2007; Lo, 2001).  Serotype 
A2 is generally not considered to be pathogenic to cattle (McVey et al., 1990), and  more 
regularly causes pneumonia in sheep (Highlander, 2001; McVey et al., 1990; Rice et al., 
2007).  Recently, increasing amounts of serotype A6 have been recovered from cases of 
bovine pneumonic mannheimiosis in Germany (Ewers et al., 2004), France, the United 
Kingdom (Kehrenberg et al., 2001b) and North America (Al-Ghamdi et al., 2000; Purdy 
et al., 1997).  Despite these trends, serotypes A2, A5, A6 and A9 have been shown to 
induce lesions experimentally and can be recovered from pneumonic tissue (Al-Ghamdi 
et al., 2000).   Mannheimia generated pneumonias have only been found in association 
with cattle, sheep and goats (Zecchinon et al., 2005). 
1.2.2 Reclassification 
 
The taxonomy of M. haemolytica has been elaborate and continues to evolve.  
Previous to the appreciation of BRD as a multifactoral condition, focus was directed 
towards the identification of a single causative agent for the disease.  The first noted was 
Bacterium bipolare multocidum by Theodore Kitt (1885).  It was renamed Bacillus 
bovisepticus by Flugge in 1896 (Highlander, 2001) and was subdivided into three groups 
based upon immunological, fermentation and virulence tests by Jones(1921).  Of these 
groups, two were associated with hemorrhagic septicemia (now recognized as P. 
multocida) and the other with bovine pneumonia.  Jones (1921) recommended the latter 
be classified as Pasteurella bovisepticas.  
Further examination of P. bovisepticus by Newsom and Cross (1932), lead to its 
reclassification as P. haemolytica and division into two biotypes, designated A and T, 
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based upon a strain’s ability to ferment L-arabinose or trehalose, respectively.  
Inconsistencies were found with regard to L-arabinose fermentation from multiple strains 
of biotype A (Bisgaard, 1984; Mraz, 1969). Consequently, it has become convention to 
describe isolates as either trehalose-negative or trehalose-positive rather than as biotype 
A or biotype T.   
Although the trehalose-positive and trehalose-negative classification scheme has 
been adopted in the literature, other biovariates have been described.  A total of 12 
biogroups have been characterized based upon various morphological and fermentative 
characteristics (Tefera, 2001).  However, biotyping has not been commonly employed in 
laboratories.  This is no doubt due to inconsistencies regarding both delineation of the 
existent biotypes and the lack of consistency obtained from phenotypic analysis.  Thus, 
little has been documented about the scope and prevalence of the described biogroups or 
their significance in veterinary medicine (Angen et al., 1999).    
In the 1960’s, Biberstein et al. (1960) developed an indirect haemagglutination 
test (IHA) that revealed a consistent relationship between capsular serotype and biotype.  
Seventeen serotypes within the P. haemolytica complex were subsequently identified, a 
total of thirteen within the trehalose-negative biotype (serotypes A1, A2, A5-9, A11-14, 
A16 and A17) and four within the trehalose-positive biotype (serotypes 3, 4, 10 and 15) 
(Angen et al., 2002; Highlander, 2001; Younan and Fodar, 1995). Despite the successes 
of the IHA method, approximately 10% of the isolates retrieved from ruminants are 
considered untypeable (Adamu, 2007; Jaworski et al., 1998).  Multiple untypeable 
isolates have been characterized through alternate methods including counter-current 
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immunoelectrophoresis and rapid plate agglutination tests (Donachie et al., 1984; Frank, 
1980).   
It was with the development of genomic analysis that further division in the P. 
haemolytica complex was observed.  In 1986, Mutters et al. (1986) excluded P. 
haemolytica from the genus Pasteurella sensu stricto based upon DNA-DNA 
hybridization.  This was supported by additional molecular analysis (De Ley et al., 1990; 
Dewhirst et al., 1992, 1993), but neither a new genus nor new genera was assigned at that 
time.  Multiple works also indicated that the two biotypes were incorrectly grouped into 
one species (Biberstein and Francis, 1968; Mannheim, 1983; Sneath and Stevens, 1985). 
It was not until 1990 that the members of the trehalose-positive group were reclassified as 
Pasteurella trehalosi (Bingham et al., 1990; Sneath and Stevens, 1990).  P. trehalosi has 
since been assigned to a new genus, Bibersteina trehalsoi comb. nov., based upon 
phylogenetic analysis conducted by Blackall et al. (2007).  
Angen et al. (1999) developed the current taxonomic scheme applied to organisms 
formerly recognised as the trehalose-negative biotype of the P. haemolytica complex. 
Based upon extensive evaluation of both phenotypic and genomic characteristics, the new 
genus Mannheimia was formed, under which five species currently reside (M. 
haemolytica, Mannheimia glucosida, Mannheimia granulomatis, Mannheimia ruminalis 
and Mannheimia varigena) as well as currently un-named taxa such as Bisgaard Taxon 
39 (Blackalu et al., 2001).  Of the 17 serovars initially described within the P. 
haemolytica complex, 3, 4, 10 and 15 are associated with B. trehalosi, A11 with M. 
glucosida and the remaining 12 with M. haemolytica (Adamu, 2007).   
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It is important to note that within the current classification system, molecular 
typing techniques still show significant levels of heterogeneity within strains of the same 
serovar (Davies et al., 1997a, b; Kodjo et al., 1999).  Also, it is clear that limitations are 
present with the utilization of either serotyping or phenotypic characterisation alone for 
identification of both Pasteurella and Mannheimia species.  However, recent 
development of both a multiplex PCR assay (Alexander et al., 2008b) and a real-time 
PCR assay (Guenther et al., 2008) have provided molecular means to aid in the accurate 
identification of the currently recognized species within the Mannheimia genus.  
Due to the link with pathogenicity there has been considerable effort devoted to 
characterising the differences and similarities between serotypes.  Multilocus enzyme 
electrophoresis has revealed M. haemolytica isolates to be clonal and has shown they can 
be placed into three distinct lineages that are associated with electrophoretic type, host 
species, capsule, lipopolysaccharide and outer membrane protein types (Davies et al., 
1997b).  Ribosomal RNA sequencing has revealed all serotypes to have identical rRNA 
sequences with the exception of serotype A2 and A7 for which the former differs at two 
positions and the latter data is not yet available (Davies et al., 1996).  Three structural 
capsule groups have been characterised, one that is serotype A1-like, one that is A2-like 
and a final that is A7-like (Highlander, 2001) and nuclear magnetic resonance 
spectroscopy has shown the O-chain polysaccharide of serotypes A1, A6 and A9 to be 
identical (Lacroix et al., 1993).  Curiously, despite these groupings, typing sera is 
generally found not to be cross-reactive showing a large degree of specificity for each 
serotype (Frank and Wessman, 1978).            
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1.2.3 Pathogenicity 
 
 M. haemolytica possesses multiple virulence factors which promote its adhesion, 
colonization and proliferation within the respiratory tract (Mohamed and Abdelsalam, 
2008).  These factors also aid it in circumventing host defences and clearance (Zecchinon 
et al., 2005). There are many reviews that describe in great detail what is known about 
the virulence factors of M. haemolytica (Highlander, 2001; Mohamed and Abdelsalam, 
2008; Thumbikat et al., 2005; Zecchinon et al., 2005).  A few of the key points are 
summarized below but a detailed account of each factor is not within the scope of this 
review.    
1.2.4 Virulence Factors 
 
M. haemolytica is thought to have several factors that aid in its attachment and 
colonization within the respiratory tract of calves.  These include adhesion proteins, 
capsular polysaccharide, fimbriae, sialoglycoprotease and neuraminidase (Rice et al., 
2007).  
1.2.4.1 Adhesions  
 
Adhesions are thought to play a significant role in colonization (Zecchinon et al., 
2005); however, little is known about the specific adhesions characteristic of M. 
haemolytica.  Although a locus encoding for adhesion proteins in M. haemolytica is yet to 
be documented, a putative adhesion-like sequence has been identified within the draft 
sequence of M. haemolytica (Highlander, 2001).  
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1.2.4.2 Fimbriae 
 
Fimbriae are small appendages on the surface of some Gram-negative bacteria 
that either permit or enhance adherence and colonization.  Two types of fimbriae, 
described as a large 12-nm rigid structure and a 5-nm flexible structure have been 
identified in M. haemolytica (Morck et al., 1989; Morck et al., 1987).  Both are capable 
of enhancing mucosal attachment of M. haemolytica to the epithelium of the lower 
respiratory tract (Mohamed and Abdelsalam, 2008).   
1.2.4.3 Capsule 
 
The capsule plays a significant role in defence and is integral in both the 
resistance of complement-mediated lysis (Chae et al., 1990; Lo, 2001) and the prevention 
of phagocytosis by macrophages and polymorphonuclear leukocytes (Chae et al., 1990; 
Lo, 2001; Mohamed and Abdelsalam, 2008). The polysaccharide capsule has been shown 
to interact with pulmonary surfactants that regulate the surface tension of the mucosal 
layer lining the alveoli and thus is also implicated with facilitating adhesion of the 
bacteria to the respiratory tract epithelium (Brogden et al., 1989; Whiteley et al., 1990).          
1.2.4.4 Neuraminidase 
 
Production of neuraminidase by M. haemolytica facilitates colonization through 
reducing the viscosity of respiratory mucus, allowing for closer bacterial apposition to the 
cell surface (Zecchinon et al., 2005).  Although the exact mechanisms are not understood, 
the enzyme is thought to remove terminal sialic residues from mucin, a respiratory mucus 
and thereby modifying host immunity (Mohamed and Abdelsalam, 2008).      
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1.2.4.5 Outer membrane proteins 
 
 Outer membrane proteins and lipoproteins are believed to be important protective 
antigens of M. haemolytica (Highlander, 2001).  Many are of interest as potential vaccine 
candidates as they have been implicated in protecting against phagocytosis and 
complement-mediated killing (Pandher et al., 1998).  They are also thought to be 
involved in remodelling of the host cytoskeleton (Highlander, 2001).  
1.2.4.6 Proteases 
 
All serotypes of M. haemolytica produce a zinc metalloglycoprotease which can 
cleave cell-surface glycoproteins from macrophages or other leukocytes (Abdullah et al., 
1991; Sutherland et al., 1992).  This enzyme has the ability to act at the host-cell surface 
and enhance adhesion (Highlander, 2001).  Its activity has been shown to be enhanced by 
incubation with leukotoxin (Nyarko et al., 1998). 
  M. haemolytica serotype A1 also produces an IgG1-specific protease (Lee and 
Shewen, 1996).  As IgG is the primary secretory antibody in the lower respiratory tract of 
cattle (Highlander, 2001), the IgG1-specific protease is thought to reduce the 
effectiveness of antibodies and thus contribute significantly to the pathogenesis of bovine 
pneumonic mannheimiosis (Lee and Shewen, 1996).     
1.2.4.7 Lipopolysaccharide (LPS) and leukotoxin (Lkt) 
 
 The two most important virulence factors possessed by M. haemolytica are its 
endotoxin (Lipopolysaccharide or LPS) and exotoxin (leukotoxin or Lkt) (Dassanayake et 
al., 2007).  Both have been well studied, particularly in serotype A1.   
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1.2.4.7.1 Lipopolysaccharide endotoxin  
 
LPS is one of the main virulence factors involved with bovine pneumonic 
mannheimiosis.  It represents 10-25% of the dry matter of M. haemolytica (Keiss et al., 
1964) and eight different variants have been described for serotype A1 alone (Davies and 
Donachie, 1996).  Both a rough and smooth form of LPS exist and serotypes A2 and A8 
have been shown to possess the rough variety while the remaining serotypes possess the 
smooth form (Lacroix et al., 1993).  LPS is directly toxic to epithelial cells and can alter 
leukocyte function and cause lysis of blood platelets (Mohamed and Abdelsalam, 2008).  
It is an inducer of inflammation and initiates both coagulation (clotting) and complement 
(immune system) cascades (Cusack et al., 2003).  More specifically, LPS induces 
macrophage production of proinflammatory cytokines, which can induce localized 
haemorrhage, edema and thrombosis (Breider et al., 1990).   It can also increase vascular 
permeability which can lead to an accumulation of inflammatory cells, particularly 
neutrophils, and both intravascular and extravascular fibrin deposition in the lung 
(Corbeil et al., 1985).  In addition to this, LPS can form complexes with leukotoxin 
which can enhance both Lkt stability and cytotoxicity (Li and Clinkenbeard, 1999).      
1.2.4.7.2 Leukotoxin 
 
The M. haemolytica leukotoxin (Lkt) is a pore forming, calcium-dependant 
cytotoxin of the RTX family of toxins (Highlander et al., 2000; Jeyaseelan et al., 2002; Li 
and Clinkenbeard, 1999).  It has specificity for ruminant leukocytes and platelets 
(Clinkenbeard and Upton, 1991; Shewen and Wilkie, 1982) and is considered the primary 
virulence factor produced by all serotypes (Burrows et al., 1993; Saadati et al., 1997).  
There are eleven distinct forms described (Davies and Baillie, 2003) and although the 
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function of M. haemolytica Lkt is highly conserved, considerable heterogeneity in its 
production rate, molecular weight and biological activity has been described even within 
strains of the same serotype (Saadati et al., 1997).  M. haemolytica Lkt is typically 
secreted in abundance during the logarithmic phase of growth (Zecchinon et al., 2005).   
The effects of Lkt range from disruption of cell function to lysis of ruminant 
leukocytes (Rice et al., 2007).  At low concentrations, Lkt activates alveolar macrophages 
and neutrophils (Jeyaseelan et al., 2002), inducing the release of various inflammatory 
mediators, including toxic oxygen radicals, proteases (Maheswaran et al., 1992; Rice et 
al., 2007), eicosanoids, proinflammatory cytokines (Yoo et al., 1995), lipid mediators 
(Clinkenbeard et al., 1994; Henricks et al., 1992; Wang et al., 1998) and nitric oxide 
(Yoo et al., 1996).  At higher concentrations, Lkt is cytocidal to bovine alveolar 
macrophages and neutrophils (Berggren et al., 1981; Maheswaran et al., 1980).  Cytolysis 
of these leukocytes results in the release of proteolytic enzymes and proinflammatory 
substances that cause damage to the alveolar lining (Jeyaseelan et al., 2002).  These 
substances are also chemotactic for various types of inflammatory cells and amplify 
damage to the lung tissue by increasing cell recruitment to the area (Zecchinon et al., 
2005).              
1.2.4.8 Other virulence factors 
 
 In addition to the above factors other intrinsic components that may contribute as 
virulence factors include iron-regulated outer membrane proteins, toxic outer membrane 
proteins, iron acquisition proteins, transferrin-binding proteins and extracelluar enzymes 
(Lo, 2001; Mohamed and Abdelsalam, 2008; Rice et al., 2007).  Also, a quorum sensing 
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model was recently described for M. haemolytica that may play a significant role in 
coordinating the virulence factors just described (Malott and Lo, 2002).  
 
1.3 Mechanics of bovine pneumonic mannheimiosis 
 
Bovine pneumonic mannheimiosis is recognized as a condition of acute febrile 
respiratory disease with fulminating fibrinous lobar pneumonia or fibrinopurulent 
bronchopneumonia and fibrinous pleurisy (Mohamed and Abdelsalam, 2008).  It is a 
pneumonic state characterised by edema and fibrin deposition within the lungs and 
pleura, typified more specifically, by the presence of degraded neutrophils and 
macrophages along with fibrin, blood and seroproteinaceous fluid within the alveoli, 
bronchi and bronchioles (Highlander, 2001).  Onset occurs within hours of infection and 
is associated with extensive parenchymal necrosis caused by M. haemolytica leukotoxin, 
lipopolysaccharide and inflammatory factors released by neutrophils as well as other 
inflammatory response cells (Ackermann and Brogden, 2000; Rice et al., 2007).  
Thrombosis and distension are observed in the pulmonary interlobular septae due to 
infusion with gelatinous material containing edema, fibrin, leukocytes, and distended 
lymphatics (Rice et al., 2007; Zecchinon et al., 2005).  Necrosis is often extended across 
the interlobar septae into adjacent lobules (Ackermann and Brogden, 2000).  
Inflammation of airways initiates at the terminal bronchioles and although bronchi 
maintain normal walls, necrosis and desquamation of epithelial cells may occur 
(Zecchinon et al., 2005).   
The disease is initiated by viral and bacterial agents that break down the 
antimicrobial barrier of β-defensins, anionic peptides, serous and mucous secretions of 
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the respiratory tract, allowing M. haemolytica to transform from a commensal to a 
pathogenic state (Brogden et al., 1998).  M. haemolytica  subsequently migrates through 
gravitational drainage along the tracheal floor into the lower respiratory tract (Mohamed 
and Abdelsalam, 2008).  At this point it is believed to attach itself to the alveoli through 
reactions between the alveolus surfactant layer and its capsular polysaccharide 
(Ackermann and Brogden, 2000).  This binding may be further enhanced by the activity 
of neuraminidase whose production is accompanied by increased rates of cell replication 
(Frank et al., 1996; Straus et al., 1998).  As a point of interest, studies suggest that M. 
haemolytica has the ability to alter its glycoconjugate expression, enhancing both its 
invasiveness and colonization (Frank et al., 1996; Straus et al., 1998). 
Once M. haemolytica is resident within the lung, an inflammation response is 
initiated due to the release of LPS, polysaccharide and Lkt into the intra-alveolar 
exudates, as well as the uptake of LPS by neutrophils and the localization of 
polysaccharide in the alveolus and alveolar macrophages (Ackermann and Brogden, 
2000).  Inflammation is mediated by multiple cell types, including endothelial cells, 
macrophages, neutrophils, mast cells, nerve fibres and epithelial cells (Ackermann and 
Brogden, 2000). A series of inflammatory mediators are released during acute M. 
haemolytica pneumonia including IL-1, TNF-α and IL-8, leukotriene B4, histamine, 
prostaglandin E2 and platelet-activating factor (Ackermann and Brogden, 2000).    
The major determinant of M. haemolytica pathogenesis is the host-pathogen 
interaction between Lkt, leukocytes and the neutrophil-mediated inflammatory response 
(Zecchinon et al., 2005). Lkt has no direct effect on vascular endothelial cells (Sharma et 
al., 1992); rather it acts as a catalyst for damage by stimulating both the activity and 
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cytolysis of neutrophils and macrophages (Highlander, 2001).  Cytolysis of neutrophils 
releases enzymes such as elastase and acid hydrolases along with oxidative radicals and 
cytokines that cause membrane damage, vascular leakage of protein and the formation of 
conjugated dienes (Ackermann and Brogden, 2000).  These damage the lung mucosa and 
expose the lung tissue to inflammatory mediators and bacteria present within the exudates 
(Ackermann and Brogden, 2000). Endotoxins (LPS) cause thrombosis of pulmonary 
veins, capillaries and lymphatics eventually leading to focal ischaemic necrosis of the 
pulmonary parenchyma and a severe inflammatory reaction (Mohamed and Abdelsalam, 
2008).   
The severity of lesions produced in bovine pneumonic mannheimiosis is 
dependent upon the infecting strain’s virulence.  Virulence determines the degree of 
bacterial colonization, the amount of endotoxin released and the degree to which the 
defences of the host are impaired (Mohamed and Abdelsalam, 2008).  Once infected, the 
anatomic features of the lung make it difficult to alleviate the factors that lead to 
pneumonia.  The lungs of cattle have few pores of Kohn between alveolar units and 
extensive interlobular septa that result in reduced collateral ventilation and alveolar 
expansion ultimately limiting the capacity for expulsion of alveolar exudates (Ackermann 
and Brogden, 2000).    
 
1.4 Management strategies 
 
The complex nature of BRD provides challenges for both prevention and 
treatment.  Because there is more than one causative agent for the condition, control of 
just one factor does not necessarily alleviate the problem.  Many feel that a complete 
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management program is necessary in order to manage the disease (Rice et al., 2007; 
Thomson and White, 2006).  Presently, BRD management strategies include 
preconditioning programs, vaccinations and antimicrobial therapy. 
1.4.1 Preconditioning/pre-weaning programs 
 
It has been argued that the best way to manage BRD is to reduce or eliminate the 
stressors that predispose animals to infection in the first place (Cusack et al., 2003).  Pre-
conditioning is a concept designed to implement management practices around weaning 
that will reduce stress and optimize both the animal’s immune system and nutritional 
status (Lalman and Smith, 2002).  Pre-conditioning programs vary, but generally involve 
a weaning period, vaccinations, treatment with antihelmenthics, castration, dehorning and 
acclimatization to feed bunks and water troughs (Thomson and White, 2006).  This kind 
of management requires commitment on the part of producers and the economic gains 
associated are still debated (Pritchard and Mendez, 1990; Waggoner et al., 2005). 
Generally, adoption of pre-conditioning programs has not been successful although pre-
weaning programs have generated some interest (Bowland and Shewen, 2000).  These are 
essentially the same as pre-conditioning but exclude any acclimatization of animals to 
feed or water.   
1.4.2 Vaccines  
 
The use of vaccines is common in feedlots; however there are few challenge 
studies that evaluate the efficacy of such programs (Bowland and Shewen, 2000).  
Regardless, a significant amount of the BRD literature promotes both the development 
and use of vaccines over the use of antimicrobials.  The main priorities of vaccination 
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programs are to stimulate an immune response, prevent shedding of the antigens and 
improve performance through decreasing subclinical disease (Thomson and White, 
2006).  Many feedlots will utilize viral antigens for calves upon entry and to a lesser 
degree will use bacterial vaccines (Thomson and White, 2006).  Commercial vaccines 
currently available for use in Canada protect against IBRV, BVDV, BRSV, PI-3V, 
P.haemolytica, and H. somnus (Bowland and Shewen, 2000).  Vaccines against M. 
haemolytica are problematic as they require serological information of the infecting strain 
to be effective (Kehrenberg et al., 2001b).  Because vaccination against M. haemolytica is 
often ineffective (Kehrenberg et al., 2001b), antimicrobial therapy is the most common 
therapy (Catry et al., 2005).  
1.4.3 Antimicrobials  
 
 Antimicrobial use is considered the primary and most effective method for 
prevention and treatment of BRD (Watts et al., 1994).  Although immunization programs 
are also frequently employed, in North America it is considered standard procedure to 
administer metaphylactic treatment to a population of calves either upon arrival into the 
feedlot or at some point shortly thereafter (Rice et al., 2007). Products that sustain blood 
levels of antibiotics for 48-72 hours or more are preferred as a means of decreasing 
labour costs and treatment stresses through reduced handling (Rice et al., 2007).  This 
type of treatment is typically administered to entry populations as the early stages of 
BRD are too difficult to diagnose during the period of delay between the time of 
vaccination and the generation of a immune response (Thomson and White, 2006).  
Metaphylactic use of antimicrobials has been alleged to reduce morbidity by 50% 
(Thomson and White, 2006). It has been estimated that 80% of the antimicrobials 
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licensed for use in cattle are designed for treatment against agents of BRD (Bowland and 
Shewen, 2000).  A list of some common antimicrobials administered to cattle is presented 
in Table 2 (Carson et al., 2008; Thomson and White, 2006) .   
 
Table 1.2    
Antimicrobials commonly administered to feedlot cattle  
Antimicrobial Trade Name Family 
Administration 
Method 
ceftiofur Naxcel  cephalosporin injectable 
florfenicol Nuflor Phenicol injectable 
tilmicosin Micotil Macrolide injectable 
tylosin Tylan Macrolide feed 
tulathromycin Draxxin Macrolide injectable 
oxytetracycline Terramycin Tetracycline injectable, feed, water 
chlortetracycline Aureomycin Tetracycline feed, water 
spectinomycin Trobicin aminocyclitol injectable 
lincomycin-
spectinomycin SpecLinx-50 
lincosamide/ 
aminocyclitol water 
monensin Rumensin 
polyether 
ionophore feed 
enrofloxacin Baytril fluoroquinolone injectable 
 
 
1.5 Antimicrobial resistance 
1.5.1 Development of antimicrobial resistance 
 
Concerns over increasing antimicrobial resistance have led to the formation of 
multiple national surveillance programs designed to detect and monitor changes in 
antimicrobial susceptibility patterns of organisms relevant to both the food industry and 
human health.  Programs have been established in Canada (Canadian Integrated Program 
for Antimicrobial Resistance Surveillance -CIPARS) and the USA (US National 
Antimicrobial Resistance Monitoring System - NARMS), as well as various European 
countries (Hendriksen et al., 2008).  As a result, information regarding the antimicrobial 
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resistance of both Pasteurella and Mannheimia spp. are available from many countries, 
including  France, Germany, the United Kingdom, the Netherlands, and Portugal 
(Kehrenberg et al., 2001b), Belgium (Catry et al., 2005), and North America (Post et al., 
1991; Watts et al., 1994).  
1.5.2 Antimicrobial resistance in M. haemolytica 
 
Providing a synopsis of antimicrobial resistance in M. haemolytica is complicated.  
This is due to two factors.  One is the tendency towards conjunctive studies that focus on 
both M. haemolytica and P. multocida within the same document and the second is the 
ambiguity generated from the taxonomic amendments made within the group over the 
past twenty years.  The outcome of the former is the frequent culmination of resistance 
data into a ‘Pasteurella group’ profile.  Although both M. haemolytica and P. multocida 
are closely related, each is a unique organism and their antimicrobial resistance profiles 
vary substantially.  The inclination to document resistance on the group level can give a 
misleading impression about the diversity between the two.  The outcome of the latter is 
varying levels of uncertainty regarding the identities of the organisms examined.  Studies 
that have supplied serological data allow for differentiation between those within the P. 
haemolytica group that are now M. haemolytica, however, those that don’t, require the 
data to be interpreted at the group rather than the species level.  It is important to keep in 
mind that those studies produced prior to 1999 can only be reported as P. haemolytica 
rather than M. haemolytica so both terms are encountered throughout this document.  
Antimicrobial resistance in M. haemolytica is already well documented and the 
basic trend is towards increasing amounts of resistance to a large number of 
antimicrobials (Watts et al., 1994).  The most common types of resistance reported are to 
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beta-lactams, tetracycline, streptomycin, chloramphenicol, sulfonamides, trimithoprim, 
macrolides and sulfamethazines (Catry et al., 2005; Highlander, 2001; Kehrenberg and 
Schwarz, 2001; Watts et al., 1994).  A few studies have been conducted that survey the 
trends in susceptibilities of M. haemolytica isolates and they are discussed further. 
However, it is important to note that not reflected in this summary is the high degree of 
variability often encountered over sampling periods. 
  In 1989, an extensive study reviewed the antimicrobial susceptibilities of close 
to five hundred P. haemolytica isolates collected from diseased cattle in USA (Post et al., 
1991).  They found high levels of susceptibility to ceftiofur, gentamicin, and sulfa-
chlorpyridazine, moderate susceptibility to erythromycin, and resistance to ampicillin, 
penicillin, sulfadimethoxine, tetracycline, and tylosin.  A four-year study conducted by 
Watts from 1988 to 1992 (1994) revealed frequent resistance of P. haemolytica isolates 
(n= 461) to ampicillin, tetracycline, erythromycin and sulfamethazine.  All isolates 
screened were susceptibile to ceftiofur and an increase in the resistance to timlicosin was 
observed, a result that was thought to be linked to cross-resistance to erythromycin 
(Watts et al., 1994).  In a review of antimicrobial resistance in Pasteurella and 
Mannheimia species, Kehrenberg (2001b) summarized data collected from P. 
haemolytica isolates from both France and Germany.  The data from France is strictly 
from 1997 (n ≤ 1015), however the information available from Germany spans 1990-
1996 (n=3524), and 1997 (n ≤ 469) (Kehrenberg et al., 2001b).  The overall susceptibility  
of P. haemolytica isolates from France tended to be lower than those from Germany and 
there was a clear decline over time in the susceptibility of the German isolates, 
particularly with regard to tetracycline, chloramphenicol, gentamicin and penicillin 
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(Kehrenberg et al., 2001b).  Although data was not provided, the review also reported 
continued susceptibility to ceftiofur, cefquinome and florfenicol and in the majority of 
cases, susceptibility to enrofloxacin, erythromycin, spiramycin, tylosin, and tilmicosin 
(Kehrenberg et al., 2001b).  
Isolates collected in the USA from 1994 through 2002 revealed susceptibilities for 
ceftiofur, cephalothin, enrofloxacin, sulfachloropyridizine and 
trimethoprim/sulfamethoxazole to be consistently high (85% and above), whereas 
susceptibility to  erythromycin, florfenicol, spectinomycin, and tilmicosin (n= 390) 
tended to decline over the collection period (Welsh et al., 2004).  Work conducted by 
Catry et al. (2005) between 2002 and 2003 reported the overall  prevalence rate of 
resistant  isolates from dairy, beef and veal calves to be 21.9%, with resistance to 
ampicillin, oxytetracycline, potentiated sulfonamides, gentamicin, tilmicosin, and 
enrofloxacin frequently encountered and resistance to ceftiofur and florfenicol not 
detected (n= 15).  Most recently, the results of a three-year survey documented high 
levels of resistance to ampicillin, tetracycline and trimethoprim/sulphonamide in France, 
the Netherlands and Portugal (n ≤ 529) (Hendriksen et al., 2008).      
The monitoring of antimicrobial resistance is critical to aid practitioners in the 
prudent use of antimicrobials.  Veterinarians typically rely upon the information available 
in textbooks or from reported surveillance data to guide their choices for drug therapy 
(Caprioli et al., 2000).  It is important that information is up to date and relevant to equip 
them with the knowledge they need to make effective decisions.  The imprudent use of 
antimicrobials leads to an increased risk for the selection of resistant bacteria and the 
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promotion of any resistance already present.   This ultimately results in reduced efficacy 
of the agents presently available leading to potential treatment failure. 
1.5.3 Genetic determinants 
 
Most of the resistance genes identified in M. haemolytica are associated with 
mobile genetic elements such as small plasmids or transposons (Kehrenberg and 
Schwarz, 2001; Zecchinon et al., 2005).  Of the resistance determinants characterised, 
few are considered indigenous to Pasteurella or Mannheimia suggesting that they have 
been acquired from other bacteria through horizontal gene transfer (Kehrenberg et al., 
2001b).  Recent data highlights the capacity of M. haemolytica to be naturally competent 
(Gioia et al., 2006) and several studies have documented its suspected propensity for 
horizontal gene transfer (Davies et al., 2002; Kelley et al., 2007; Wood et al., 1995).  
Consequently, M. haemolytica should be recognized as a potential candidate for the 
transfer and spread of antimicrobial resistance.   
1.5.3.1 Resistance to β-lactams 
 
BlaROB-1 is the only of three β-lactamase genes (blaROB-1, blaTEM-1, and blaPSE-1), to 
be detected in M. haemolytica.  It is a member of the Ambler Class A (Bush class 2b) of      
β-lactamases and can hydrolyse penicillins and narrow-spectrum cephalosporins 
(Kehrenberg et al., 2006).  It does not display extended spectrum β-lactamase activity or 
mediate resistance to the newer generations of cephalosporins such as ceftiofur or 
cefquinome and can be inactivated by clavulanic acid (Kehrenberg et al., 2006).  The 
gene is encoded on small plasmids and is widely distributed among the Pasteurelleacea 
(Highlander, 2001).  Not surprisingly, a strong genetic homology has been observed 
  30 
between blaROB-1 genes collected from P. multocida, P. haemolytica, H, influenzae and A. 
pleuropneumoniae (Kehrenberg et al., 2006).           
1.5.3.2 Tetracyclines 
 
 Tetracycline resistance is found frequently in members of the family 
Enterobacteriaceae but rarely in the Pasteurella species (Hansen et al., 1996).  This is 
thought to be due to the ineffectiveness of Pasteurella species at transcribing Escherichia 
coli genes (Hansen et al., 1996). However, some cases of tetracycline resistance have 
been encountered in M. haemolytica and are summarized below.  
The tetracycline resistance observed within the Pasteurella, Mannheimia, 
Actinobacillus, and Haemophilus groups is diverse.  There have been seven different 
genes identified that represent two different mechanisms, including the active efflux 
genes tetH, tetB, tetG, tetK, tetL and the ribosomal protective proteins tetM and tetO 
(Kehrenberg et al., 2006).  Both the prevalence and occurrence of each gene varies within 
the Pasteurellaceae family with the overall frequency of tetracycline-resistance being 
higher in M. haemolytica than in P. multocida (Catry et al., 2003).  
 The tetH allele is most commonly observed in M. haemolytica (Highlander, 
2001).  It was first recognized in P. multocida in 1993 (Hansen et al., 1993) and was 
subsequently discovered in isolates of P. haemolytica recovered from cattle in North 
America (Hansen et al., 1996).  It is assumed to be associated with a transposable element 
as it has been detected on plasmids and integrated into the chromosome (Hansen et al., 
1996).  TetG was recently detected on the chromosomes of multiple related isolates of M. 
haemolytica (Kehrenberg et al., 2001a) and tetL has been recovered from both plasmid 
and chromosomal DNA of M. haemolytica (Kehrenberg et al., 2005b).  The tetB gene is 
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the most widely spread tetracycline resistance gene among the Enterobacteriaceae 
(Chopra and Roberts, 2001), however, it has only been documented once in an isolate of 
P. haemolytica collected from a bovine sample in France (Chaslus-Dancla et al., 1995).   
1.5.3.4 Aminoglycosides and aminocyclitols 
 
 The strA gene is the most common streptomycin resistance determinant found in 
Mannheimia and Pasteurella species (Kehrenberg et al., 2006).  It mediates resistance 
through production of an aminoglycoside-3’-phosphotransferase which enzymatically 
inactivates the drug (Kehrenberg and Schwarz, 2001).  It is sometimes found in 
conjunction with a whole or truncated form of strB which codes for an  
aminoglycoside-6’-phosphotransferase (Kehrenberg et al., 2006).  This strA-strB 
combination shows high resistance to streptomycin and is present on the plasmids or 
integrated into the chromosome of many pathogenic and commensal bacteria 
(Kehrenberg et al., 2006).   
 Spectinomycin is an aminocyclitol also used for treatment in cattle.  There have 
been cases of high-level resistance to the drug documented in M. haemolytica 
(Kehrenberg and Schwarz, 2001) however, recent work undertaken to describe 
spectinomycin resistance was unsuccessful (Schwarz et al., 2004).  Although the first 
addA14 gene was recently detected on a plasmid from a bovine P. multocida isolate, it 
was concluded that the genes responsible for spectinomycin and 
spectinomycin/streptomycin resistance in Pasteurella and Mannheimia organisms are yet 
to be described (Kehrenberg et al., 2005a). 
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1.5.3.5 Sulfonamides 
 
 Sulfonamide resistance is one of the most frequently detected resistances in M. 
haemolytica and is typically mediated by the SulII gene which codes for a type II 
dihydropteroate synthase (Kehrenberg and Schwarz, 2001).  This gene has been found on 
plasmids of varying size and sequence analysis shows it to display a significant degree of 
heterogeneity (Kehrenberg et al., 2006).  It has also often been found linked to  strA-strB 
genes (Kehrenberg et al., 2006) and has been associated with kanamycin and/or 
tetracycline resistance (Kehrenberg and Schwarz, 2001).  
Trimethoprim resistance is usually mediated through dihydrofolate reductases 
which have been found located on plasmids, transposons or gene cassettes (Kehrenberg et 
al., 2006).  Studies on trimethoprim resistance in M. haemolytica have exposed the lack 
of its association with plasmids or its ability to hybridize with gene probes specific to 
dhfrI to dhfrV (Escande et al., 1991).  A novel trimethoprim resistance gene, dfrA20, has 
recently been described from a plasmid present in  a bovine P. multocida isolate 
(Kehrenberg and Schwarz, 2005a).         
1.5.3.6 Chloramphenicol and florfenicol 
 
 Chloramphenicol resistance is typically mediated by either chloramphenicol 
acetyltransferases or chloramphenicol exporters; the genes for which are located on 
plasmids, transposons or gene cassettes (Kehrenberg et al., 2006).  Three types of 
inactivating enzymes have been described, catA1 to catA3, based upon biochemical and 
immunological properties as well as their vulnerability to inhibition by 5,5’-dithiobis (2-
nitrobenzoic acid) (Vassort-Bruneau et al., 1996).  Chloramphenicol resistance has been 
documented in M. haemolytica and is attributed to the genes catA1 and catA3.  The catA2 
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gene has been detected in Haemophilus spp., but has yet to be observed in Mannheimia 
(Kehrenberg et al., 2006).  
 So far, the fluorinated chloramphenicol derivative florfenicol is still effective 
against M. haemolytica.  However, a pp-flo gene encoding for the export of 
chloramphenicol/florfenicol has been identified in the fish pathogen Pasteurella piscicida 
(Kim and Aoki, 1996) and a similar gene, floR has recently been detected in a bovine P. 
multocida isolate collected in the United Kingdom (Kehrenberg and Schwarz, 2005b).    
 
1.6 M. haemolytica and the feedlot industry in Canada  
 
 Little has been published about the economics and epidemiology of BRD within 
Canadian feedlots and of the information available, much is out-dated.  Estimates 
generated in 1978 place the cost of respiratory disease in Alberta feedlots to be $9.6 
million annually (Church and Radostits, 1981).  A more recent study reported that 29%-
45% of the cases of respiratory disease related death in Ontario feedlots and 10%-57% of 
the cases of respiratory disease related death in western Canada were due to shipping 
fever pneumonia or pneumonic mannheimiosis (Gagea et al., 2006), but these values 
reference back to the late 70’s and 80’s.  Indeed, the only information uncovered by the 
author relating to the occurrence and economics of BRD in Canada date back prior to 
1999 (Booker et al., 1999; Church and Radostits, 1981; Harland et al., 1991; Martin et al., 
1981; Martin et al., 1980; Ribble et al., 1995a; Ribble et al., 1995b).  In addition to a 
general lack of information, much of what is reported is measured as total morbidity or 
total mortality values. Total morbidity values may be misleading as a there has been a 
clear lack of association described between the clinical symptoms of BRD and the lung 
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lesions characteristic of the condition (Wittum et al., 1996).  Furthermore, the definition 
of each morbidity and mortality due to BRD can vary between studies making total 
morbidity and total mortality crude dependant variables for epidemiological studies 
(Ribble et al., 1995b). 
 Few studies in Canada have focused on M. haemolytica as a primary agent of 
BRD.  Work conducted in Ontario in 1978-79 documented a 25% isolation rate of P. 
haemolytica from deceased cattle.  However, the majority of recent publications are 
directed towards describing the efficacy of various antimicrobial treatments against this 
pathogen (Booker et al., 1997; Hoar et al., 1998; Jim et al., 1999; Schunicht et al., 2002).  
This highlights both the reliance of the Canadian feedlot industry on antimicrobial usage 
for the treatment of BRD, as well as the lack of enthusiasm surrounding epidemiological 
studies of BRD within our country.  It has been proposed that part of the difficulty in 
amassing data pertaining to BRD in Canada is due to the confidentiality clauses put in 
place by feedlot managers (Church and Radostits, 1981).  Given this circumstance it 
should not be unexpected that little progress has been made towards reducing the impact 
of BRD in Canada.   
Understanding the ecology of M. haemolytica within the feedlot setting is crucial 
to developing a means to manage it.  To our knowledge no work has been conducted 
examining the diversity of M. haemolytica populations upon arrival and exit from 
Canadian feed yards neither in relation to genetic profiling, nor antimicrobial 
susceptibility profiles.  The former is of considerable concern as recent taxonomic 
amendments have emphasized the necessity for genetic characterization in the proper 
identification of Mannheimia species and there has been an obvious link established 
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between the diversity observed within the species and its potential for pathogenicity.  In 
regards to antimicrobial susceptibility profiling, defining the relationship between 
antimicrobial use (AMU) and antimicrobial resistance (AMR) in the feedlot sector is 
necessary to identify the risks associated with treatment.   
In most cases, the study of antimicrobial use in the livestock industry leads many 
to adopt the ostrich attitude of ‘it is better not to know’ with the main concern being, that 
documentation of antimicrobial resistance will lead to the restricted use of antimicrobials.  
The reality is that despite its detection, the development of antimicrobial resistance is 
inevitable.  However, responsible use of antimicrobials within the feedlot environment 
can greatly reduce the speed and severity with which AMR occurs. Obtaining a clearer 
understanding of the interaction between AMU and AMR in cattle production will 
ultimately aid producers by giving them the information needed for the prudent use of 
antimicrobials for prevention and treatment of BRD.    
 A key objective of this work is to fill in the gaps in knowledge about the ecology 
of M. haemolytica within the Canadian cattle industry.  The aim of the study is to 
characterize the diversity of M. haemolytica isolates collected from cattle upon arrival 
and exit from two feedlots in Southern Alberta, focusing on their genetic profiles through 
molecular analysis using pulsed-field gel electrophoresis and antimicrobial resistance 
profiles using a disk diffusion assay.   
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CHAPTER TWO 
 
A method to improve pulsed-field gel electrophoresis analysis of Mannheimia 
haemolytica 
 
2.1 Introduction 
 
Mannheimia haemolytica is the primary bacterial pathogen implicated in Bovine 
Respiratory Disease complex (BRD), one of the most important health concerns in cattle 
production.  Recent reclassification of the Pasteurella haemolytica-complex, forming the 
genus Mannheimia (Angen et al., 1999), has revealed the importance of M. haemolytica 
in the development of BRD and has also highlighted gaps in the epidemiology of this 
pathogen.  Studies have investigated the prevalence of serotypes isolated from cattle 
(Angen et al., 2002; Katsuda et al., 2007), but there are few reports on the genetic 
relatedness of M. haemolytica isolates.  Such information is important in order to gain a 
better understanding of the epidemiology of this pathogen.  
Pulsed field gel electrophoresis (PFGE) is commonly used for molecular typing 
bacteria and several studies have already applied this technique to M. haemolytica.  
PFGE is considered both highly discriminatory and reproducible (Foxman et al., 2005; 
Tenover et al., 1997); however, both of these factors are dependant on the quality of the 
restriction profiles created.  The resolution of the bands produced and the quality of the 
reference or size standard are critical to genotyping analyses. Size standards are of 
particular significance because they are an essential factor for the normalization of gels, 
construction of databases and comparisons of genetic profiles between laboratories. 
The size standards most commonly reported in PFGE analysis of M. haemolytica 
are pre-manufactured Pulse Markers comprised of lambda DNA concatemers (Katsuda et 
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al., 2003; Villard et al., 2006).  In our preliminary trials we found the band compression 
and resolution of these standards to be poor.  In addition, PFGE analysis of M. 
haemolytica digested with SalI restriction endonuclease (Kodjo et al., 1999; Villard et al., 
2006) requires the use of both high range (50-1000kb) and low range (0.1-200kb) Pulse 
Markers to encompass the range of DNA fragments produced.  The method described 
here provides an alternative to the reference standards currently used for PFGE analysis 
of M. haemolytica and also provides tactics to improve band resolution by adjusting the 
PFGE conditions from those currently reported in the literature.  The results presented 
compare the use of a lambda based Pulse Marker size standard with a Salmonella based 
standard and show the effect of reduced running temperature and the addition of thiourea 
to running buffer on the resolution of restriction profiles.   
 
2.2 Materials and Methods 
Plugs and gels were prepared according to PulseNet USA protocols (CDC, 1996).  
M. haemolytica isolates were cultured overnight at 37 ºC on 5% sheep blood agar 
containing 15 μg/ml of bacitracin according to Catry et al (2007).  For each isolate, 
colonies were suspended in 2 ml of Cell Suspension Buffer (0.1M Tris; 0.1M EDTA, pH 
8.0) to the equivalent of a 5 McFarland suspension (absorbance reading between 1.25 and 
1.35 at 610 nm).  Salmonella serotype Braenderup (H9812) used for the size standard was 
cultured in the same conditions on Luria-Bertani agar.  Plugs of both species were 
prepared by combining 100µL each of  the culture suspension and 1% SeaKem Gold 
low-melting temperature agarose (Lonza Canada, Inc., Shawinigan, QC) containing 10% 
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sodium dodecyl sulphate (SDS) with 10µL of 20 ng/ml Proteinase K (Roche Diagnostics 
Canada, Ltd., Mississauga, ON).  
Plugs were incubated in a water bath at 54 ºC with constant agitation at 100 rpm 
for 3 h in 50-ml plastic tubes containing 5 ml cell lysis buffer (0.05 M Tris pH 8.0, 0.05 
M EDTA pH 8.0, 1% Sarcosyl) and 25 µl of 20 ng/ml Proteinase K.  Plugs were washed 
twice with 10-15 ml of sterile ultra pure water (Fischer Scientific Co., Ottawa, ON) and 
four times with 10-15 ml sterile 1xTE (10 mM Tris, 1mM EDTA, pH 8.0) for periods of 
15 min at 54 ºC and 100 rpm. The washed plugs were stored in sterile 1xTE buffer and 
refrigerated at 4 °C until use. 
M. haemolytica plugs were digested overnight at 37 ºC with 10 units of SalI 
(Invitrogen Canada, Inc., Burlington, ON) and 180 µl of appropriate buffer provided by 
the manufacturer.  Salmonella serotype Braenderup standard plugs were digested 
overnight for the same duration and temperature with 10 units of XbaI (Invitrogen 
Canada, Inc., Burlington, ON) and 180 µl of buffer provided by the manufacturer.  Two 
sizes of pre-manufactured lambda Pulse Markers were used; a low range 0.1-200 kb 
(Sigma-Aldrich Canada, Ltd., Oakville, ON) and a high range 50-1000 kb (Sigma-
Aldrich Canada, Ltd.).  Slices of Pulse Marker were cut with a blade from the end of the 
syringe according to manufactures specifications (approximately 0.5 µg in size) and 
imbedded along with digested Salmonella and M. haemolytica plugs in 1% SeaKem Gold 
low-melting temperature agarose (Lonza Canada, Inc.) that was dissolved in 0.5x TBE 
(45 mM Tris, 45 mM boric acid, 1 mM EDTA, pH 8.0).  Prior to incorporation into the 
gel, digested plugs were incubated with 200 uL of 0.5 x TBE at room temperature for 20 
min. 
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The digested DNA was separated by PFGE using a CHEF DRII device (Bio-Rad 
Laboratories (Canada) Ltd., Mississauga, ON) according to the program outlined by 
Hunter et al. (2005) for Listeria monocytogenes with exception of  an extension of the 
running time to 22 h to aid with separation of the top two bands of the Salmonella 
standard.  Gels were run at either 14 °C or 12 °C; voltage was maintained at 6 V/cm with 
switch times of 4-40 s. The gels were run in 0.5 X TBE buffer with or without the 
addition of thiourea (0.5 mM).  Gels were stained with 1 µg/ml of ethidium bromide in 
distilled water for 20 min followed by three washes in distilled water for the same 
duration.  Gels were photographed with the AlphaImager gel documentation system 
(Alpha Innotech Corp., St Leandro, CA) with constant settings for all images.  Fragment 
analysis was performed with BioNumerics V5.1 (Applied Maths, Inc., Austin, TX). 
 
2.3 Results and Discussion 
 
In all three cases (Fig. 2.1, Fig. 2.2 and Fig. 2.3), the limitations of the lambda 
Pulse Markers were evident.  Although distinct separation was achieved with the lambda 
Pulse Markers, in multiple cases the spread of the bands exceeded 30 kb.  In these 
instances we found position assignment difficult, leading to poor normalization of gels 
within the BioNumerics analysis program.  In contrast, a Salmonella size standard 
described previously (Hunter et al. 2005) provided well-defined bands that were 
consistent in breadth to the M. haemolytica samples analyzed.  We found these lanes 
more reliable for use in analysis, such as library creation and genotype profiling and 
comparisons. 
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Fig. 2.1. PFGE of M. haemolytica isolates digested with SalI endonuclease, 
Salmonella serotype Braenderup digested with XbaI and a high and a low 
Lambda Pulse Marker.  Program consisted of electrophoresis for 22 h at 
14°C with switch times from 4-40 seconds; no thiourea was added to the 
running buffer.  Lanes 1 and 11: high range Pulse Marker 50-1000kb; lanes 
2 and 10: low range Pulse Marker 0.1-200kb; lanes 3 and 9: Salmonella 
serotype Braenderup; lanes 4 to 8:  M. haemolytica isolates.  
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Fig. 2.2.  PFGE of M. haemolytica isolates digested with SalI endonuclease, 
Salmonella serotype Braenderup digested with XbaI and a high and a low 
Lambda Pulse Marker.  Program consisted of electrophoresis for 22 h at 
12°C with switch times from 4-40 seconds; no thiourea was added to the 
running buffer.  Lanes 1 and 11: high range Pulse Marker 50-1000kb; lanes 
2 and 10: low range Pulse Marker 0.1-200kb; lanes 3 and 9: Salmonella 
serotype Braenderup; lanes 4 to 8:  M. haemolytica isolates.  
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Fig. 2.3.  PFGE of M. haemolytica isolates digested with SalI endonuclease, 
Salmonella serotype Braenderup digested with XbaI and a high and a low 
Lambda Pulse Marker.  Program consisted of electrophoresis for 22 h at 
12°C with switch times from 4-40 seconds; thiourea was added to the 
running buffer.  Lane 1: low range Pulse Marker 0.1-200kb; lane 2: high 
range Pulse Marker 50-1000kb; lanes 3 and 10: Salmonella serotype 
Braenderup; lanes 4 to 9: M. haemolytica isolates.  
 
Fig. 2.1 and Fig. 2.2 contrast the effects of the reduction in running temperature 
from 14 °C to 12 °C, respectively.   Reducing the temperature by 2 °C resulted in 
improved band compression and clarity.  Fig. 2.3 shows the results from the addition to 
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thiourea to the running buffer. A slight improvement was observed in the separation of 
bands arising from the Salmonella standard, compared to when no thiourea was added 
(viz. bands one and ten).  Although thiourea has been shown to improve the quality of 
PFGE profiling in other organisms (Corkill et al., 2000; Silbert et al., 2003; Zhang et al., 
2004) its use here did not appear to significantly affect the resolution of  M. haemolytica 
bands.  However, improving the separation of the bands of the Salmonella standard 
resulted in a significant improvement in the analysis of PFGE gels.  Therefore, the 
addition of thiourea to the electrophoresis buffer was adopted when Salmonella standards 
were used for PFGE of DNA from M. haemolytica.   
To conclude, we found that utilization of the Salmonella size standard in 
conjunction with both a reduction in running temperature and the addition of thiourea to 
the running buffer to be advantageous in the PFGE analysis of DNA from M. 
haemolytica. Both resolution and clarity of restricted DNA fragments were improved by 
these procedures, allowing for better normalization of gels and comparison of M. 
haemolytica isolates by PFGE.  The utilization of Salmonella as a reference standard 
increased the consistency of gel interpretation leading to an improvement in PFGE 
analysis.  
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CHAPTER THREE 
 
Comparison of repetitive PCR and pulsed-field gel electrophoresis for analyses of 
Mannheimia haemolytica genetic diversity and identification 
 
3.1 Introduction 
 
 Mannheimia haemolytica is the principal bacterial pathogen associated with 
bovine respiratory disease (BRD) in cattle (Rice et al. 2007).  Also referred to as shipping 
fever, undifferentiated fever (UF) and/or bovine respiratory disease complex (Booker et 
al., 2008; Schunicht et al., 2007; Wildman et al., 2008), this condition is one of the most 
significant health problem facing the North American cattle industry (Snowder et al., 
2006).  The economic losses it generates surpass those incurred by all other diseases of 
cattle combined (Highlander, 2001) and are due to production losses, treatment costs and  
mortalities (Bateman et al., 1990; Gagea et al., 2006; Larson and Tyler, 2005).   
Although numerous studies have focused on the role of M. haemolytica in the 
pathology of BRD (Ackermann and Brogden, 2000; Highlander, 2001; Mohamed and 
Abdelsalam, 2008; Zecchinon et al., 2005), little is known about the role that genetic 
variability plays in the biology of this pathogen.  Information on environmental 
persistence, transmission and virulence may all be augmented if a suitable technique for 
characterizing the genetic diversity of M. haemolytica can be identified. Defining the role 
that these factors have in the etiology of BRD may provide insight into effectual 
management strategies for M. haemolytica-associated BRD within the feedlot sector.   
Current molecular genotyping methods provide multiple means by which to 
identify and monitor genetic variants within populations.  Typically utilized for species 
identification (De Vuyst et al., 2008; Masco et al., 2003), source tracking (Currie et al., 
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2007) and strain discrimination (Gunawardana et al., 2000), genotyping methods have 
become essential tools for epidemiological investigations.  Pulsed-field gel 
electrophoresis (PFGE) has been described as one of the most powerful microbial 
genotyping methods owing to its high discriminatory power (Tenover et al., 1997).   
However, PFGE has some drawbacks as it is a time consuming process and requires 
expensive, specialized equipment.  Alternative methods such as repetitive PCR have been 
presented as an alternate approach for subspecies classification and strain delineation 
(Healy et al., 2005).  These provide a more cost-effective and efficient typing method 
compared to PFGE, however they may lack discriminatory power (Foxman et al., 2005).   
Understanding the strengths and weaknesses of a chosen bacterial typing 
technique is needed in order to accurately interpret study results (Foxman et al., 2005).  
The objective of this work was to compare the capabilities of PFGE and two repetitive 
PCR techniques in the genotypic analysis of M. haemolytica.  Additional species within 
Pasteurellaceae were also analyzed to determine the potential for each genotyping 
method to identify Mannheimia spp.  
 
3.2 Materials and Methods 
 
Isolates 
 A total of 40 M. haemolytica field isolates were typed with PFGE and with the 
rep-PCR methods BOX-PCR (primer BOXA1R) and (GTG)5-PCR (primer (GTG)5).  The 
isolates originated from bovine nasal swabs collected from feedlot cattle in the southern 
region of Alberta, Canada.  Prior to use all isolates were positively identified as M. 
haemolytica through biochemical testing and multiplex PCR (Alexander et al., 2008b) 
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and stored at -80 °C.  Twenty four reference strains including Mannheimia glucosida 
(strains CCUG 28375, CCUG 28376, CCUG 38454, CCUG 38456, CCUG 38467, 
CCUG 38459, CCUG 38460), Mannheimia granulomatis (strain CCUG 45422), 
Mannheimia haemolytica (strains CCUG 18142, CCUG 24141, CCUG 29694, CCUG 
43453, CCUG 38454#, ATCC BAA-410, ATCC 43270, ATCC 33396, ATCC 29694, 
UGCC G2, UGCC G2, UGCC G5, UGCC G12 ), Mannheimia ruminalis (strains CCUG 
38470, CCUG 38466#) and Pasteurella multocida subsp. multocida (strains CCUG 
17976B) were also analyzed using the aforementioned genotyping methods.  Reference 
strains used were obtained from either the American Type Culture Collection (ATCC, 
Manassas, VA, USA), University of Göteborg culture collection (CCUG, University of 
Göteborg, Sweden) or through the University of Guelph culture collection (UGCC, 
Guelph, ON, Canada).  Salmonella serotype Braenderup (H9812) was used as a reference 
standard in PFGE.  For PFGE and PCR-based analyses, Mannheimia spp. and P. 
multocida were cultured overnight at 37 ºC on TSA agar plates containing 5% sheep 
blood agar plates.  Salmonella serotype Braenderup (H9812) was cultured under the same 
conditions with the exception of plating on Luria-Bertani agar. 
PFGE 
Plug and gel preparation were conducted according to PulseNet USA protocols 
(CDC, 1996).  For each isolate, colonies were suspended in 2 ml of cell suspension buffer 
(0.1M Tris; 0.1M EDTA, pH 8.0) to the equivalent of a 5 McFarland turbidity standard 
(absorbance reading between 1.25 and 1.35 at a wavelength of 610 nm).  Agar plugs of 
each species were prepared from suspensions containing 10 µl of Proteinase K (20 ng/ml 
in sdH2O) (Roche Diagnostics Canada, Ltd., Mississauga, ON) combined with 100 µl of 
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a culture suspension and 100 µl 1% SeaKem Gold agarose (in sterile TE, pH 8) (Lonza 
Canada, Inc., Shawinigan, QC) containing 10% sodium dodecyl sulphate (in sterile 
distilled H2O).   
Plugs were incubated in 50 ml plastic tubes containing 5 ml cell lysis buffer (0.05 
M Tris pH 8.0, 0.05 M EDTA pH 8.0, 1 % Sarcosyl in sdH2O) and 25 µl of Proteinase K 
(20 ng/ml in sdH2O) in a shaker water bath at 54 ºC with constant agitation at 100 rpm 
for 3 h.   Plugs were washed twice with 10-15 ml of sterile ultra pure water and 
subsequently four times with 10-15 ml sterile 1 × TE (10 mM Tris, 1mM EDTA, pH 8.0) 
for periods of 15 min at 54 ºC and 100 rpm. Once washed the plugs were stored in sterile 
1 × TE buffer and refrigerated at 4 °C until used. 
Plugs of Mannheimia and Pasteurella sp. were digested overnight at 37 ºC with 
10 units of SalI and 180 µl of appropriate buffer provided by the manufacturer 
(Invitrogen Canada, Inc.).  Salmonella serotype Braenderup standard-plugs were digested 
similarly with the exception of using 10 units of restriction enzyme XbaI (Invitrogen 
Canada, Inc., Burlington, ON) and 180 µl of buffer.  The digested plugs were imbedded 
in 1% SeaKem Gold low-melting temperature agarose (Lonza Canada, Inc., Shawinigan, 
QC ) that was dissolved in 0.5 × TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA, pH 
8.0).  Prior to incorporation into the gel, digested plugs were incubated with 200 µl of 0.5 
× TBE at room temperature for 20 min. 
The digested DNA were separated by PFGE using a CHEF DRII device (Bio-Rad 
Laboratories Canada, Ltd., Mississauga, ON), according to the program outlined by 
Hunter et al, (2005) for Listeria monocytogenes with exception to an extension in running 
time to 22 h to aid with separation of the top two bands of the Salmonella standard.  Gels 
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were run at 12 °C; voltage was maintained at 6 V/cm with switch times of 4-40 s. The 
gels were run in 2,200 ml of 0.5 × TBE buffer with the addition of 1 ml of 1 M thiourea.  
After electrophoresis, gels were stained with ethidium bromide (1 µg/ml) in distilled 
water for 20 min followed by three washes in equal volumes of distilled water for the 
same duration.  Gels were photographed with an AlphaImager gel documentation system 
(Alpha Innotech Corp., St Leandro, CA, USA); the settings were maintained constant for 
all images obtained.  Fragment analysis was performed with BioNumerics V5.1 software 
(Applied Maths Inc., Austin, TX, USA).  
Rep PCR 
Isolates were grown overnight on TSA agar plates containing 5% sheep blood (37 
°C).  Bacteria from approximately one half of each plate were removed using an 
inoculating loop. Genomic DNA was extracted and purified using the DNeasy Tissue Kit 
(Qiagen Canada, Inc., Mississauga, ON) according to the manufacturer’s instructions 
with only slight modifications.  Lysis was extended overnight at 4 °C and the final 
product was eluted with 180 µl of elution solution.  DNA was quantified fluorometrically 
using the Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen Canada, Inc.,) with a 
VersaFluor fluorometer (Bio-Rad Laboratories Canada, Ltd.,), diluted to 5 ng/µl with 
sterile TE (pH 7.4), and stored at -20 °C until used.   
Repetitive sequence PCR was conducted using the BOX-PCR analogous primer 
pair set (5’-CTA CGG CAA GGC GAC GCT GAC G-3’) and the (GTG)5-PCR single 
oligonucleotide primer (5’-GTG GTG GTG GTG GTG-3’) (Mohapatra and Mazumder, 
2008).  Each PCR mixture (20 µl) contained (final concentrations) 1 × HotStarTaq 
Master Mix (Qiagen Canada, Inc.), 1 × CoralLoad Concentrate Mix (Qiagen Canada, 
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Inc.), 2.0 µM primer, 0.28% dimethyl sulfoxide, and 0.1 µg/µl bovine serum albumin.  
DNA (10 ng) was added as template to each PCR.  All PCR were performed with a 
Mastercycler thermal cycler (Eppendorff Canada, Ltd., Mississauga, ON) using the 
following conditions: 95 °C for 5 min; 30 cycles of 94 °C for 30 s, 40 °C (GTG)5-PCR or 
50 °C BOX-PCR annealing temperatures for 1 min, and 72 °C for 1 min; and 72 °C for 8 
min.   
Following PCR, 20 µl of product was analyzed by agarose gel electrophoresis 
[(1.2% (w/v) SeaKem LE agarose (Lonza Canada, Inc., Shawinigan, QC)] with a setting 
of 40 V for a period of 12 h at 8 °C.  Gels were stained, washed and visualized as 
described above for PFGE.  One lane containing seven microlitres of Gene Rule DNA 
Ladder Mix (Fermentas Canada, Inc., Burlington, ON) was included with every six to 
seven samples to serve as a molecular size standard.  Fragment analysis was performed 
with the BioNumerics V5.1 software (Applied Maths, Inc., Austin, TX, USA).    
Method repeatability 
 A repeatability experiment was conducted using five randomly selected field 
isolates grown under identical conditions.  For each isolate examined, five colonies were 
selected from a single plate and subjected to the procedures described above for PFGE, 
BOX-PCR and (GTG)5-PCR.   
Statistical analysis 
All statistical analyses were performed using BioNumerics V5.1 software 
(Applied Maths, Inc.,).  Dendrograms were created using UPGMA clustering of Dice 
coefficient values with 1.00% optimization and 1.5% position tolerance settings.   
Congruence values were calculated using Kendall’s tau coefficient with a degree of one.  
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Discrimination indices were derived from the Simpson’s Diversity Index script 
downloadable from the Applied Maths web link tool (http://www.applied-
maths.com/bn/scripts/comparisons/bncomscripts.htm).  Repeatability was reported as the 
proportion of isolates that had >95% similarity based on UPGMA cluster analysis of Dice 
coefficients within the BioNumerics V5.1 program (Applied Maths, Inc., Austin, TX, 
USA).      
 
3.3 Results 
 
DNA band analysis 
 Representative profiles from each genotyping assays are depicted in Fig. 1.3. 
PFGE analysis of M. haemolytica isolates revealed bands that ranged in size from 
approximately 25 to 1000 kb.  PFGE band profiles consisted of 12.7 bands and when 
examined with Dice correlation coefficient with 1.0% optimization and 1.5% position 
tolerance settings, a total of 37 unique profiles were identified from the 40 field isolates.   
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BOX-PCR analysis of the M. haemolytica isolates revealed a band range of 
approximately 900 to 6,000 bp while the (GTG)5-PCR analysis ranged from 500 to 6,000 
bp.  BOX-PCR and (GTG)5-PCR band profiles were 10.8 and 17.8 respectively.  When 
examined with Dice correlation coefficient with 1.0% optimization and 1.5% position 
tolerance settings the 40 isolates produced 25 unique profiles with BOX-PCR and 20 
unique profiles with (GTG)5-PCR.  
Discriminatory Indices 
 Although a discriminatory index >0.90 was achieved with both PFGE and BOX-
PCR, only PFGE was capable of obtaining effective discriminatory powers of 0.98 and 
0.92 (Hunter and Gaston, 1988) when relaxing the similarity cutoff below the 95% value 
A B C
Fig. 3.1. Representative PFGE (A), (GTG)5-PCR(B) and BOX-PCR 
(C) profiles. Lanes 1 through 4 represent replicate isolates
1 2 3 4 1 2 3 4 1 2 3 4
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to 90% and 85% respectively (Table 3.1).  (GTG)5-PCR alone did not produce a 
discriminatory index above 0.72, however when used in combination with BOX-PCR a 
value >0.90 was achieved. A composite fingerprint was produced with weightings of 1:1, 
3:1 and 6:1 of BOX-PCR to (GTG)5-PCR, respectively, using BioNumerics software.  
The combined profiles increased the overall discriminatory value from that observed with 
(GTG)5-PCR alone, but none of the combinations produced discrimination greater than 
what was achieved by BOX-PCR alone. 
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Table 3.1  
Discriminatory power of PFGE, (GTG)5-PCR and BOX-PCR in genotype analysis of M. 
haemolytica field isolates  (n=40) 
Method 
Similarity 
cut-off Cluster Sizes 
Discriminatory 
Index 
    
PFGE 95 1, 1, 2, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 
1, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 
1, 1, 1, 1, 1, 1 
>0.98* 
90 1, 1, 2, 2, 2, 1, 1, 2, 1, 1, 1, 1, 1, 
1, 1, 1, 4, 2, 2, 3, 1, 1, 1, 1, 1, 1, 
1, 1, 1 
0.98 
85 2, 2, 2, 2, 1, 1, 2, 1, 1, 3, 1, 1, 1, 
11, 1, 1, 1, 1, 1, 1, 2, 1 
0.92 
80 2, 2, 2, 2, 1, 1, 3, 1, 3, 1, 13, 2, 1, 
1, 1, 1, 2, 1 
0.88 
(GTG)5-PCR 95 5, 2, 1, 1, 20, 5, 4, 1, 1 0.72 
90 7, 1, 1, 30, 1 0.42 
85 8, 1, 31 0.37 
80 9, 31 0.36 
BOX-PCR 95 4, 2, 1, 2, 2, 1, 10, 2, 2, 1, 1, 3, 1, 
1, 1, 1, 1, 2, 2 
0.92 
90 4, 2, 1, 2, 2, 1, 14, 2, 4, 1, 2, 1, 2, 
2 
0.86 
85 7, 2, 3, 16, 5, 2, 1, 2, 2 0.80 
80 9, 3, 21, 3, 2, 2 0.67 
BOX-PCR: (GTG)5-
PCR    (1:1) 
95 2, 2, 4, 3, 4, 1, 1, 2, 2, 9, 1, 3, 1, 
1, 1, 1, 2 
0.92 
90 4, 7, 5, 1, 8, 2, 1, 2 0.75 
85 4, 7, 24, 3, 2 0.61 
80 35, 5 0.22 
BOX-PCR: (GTG)5-
PCR (3:1) 
95 4, 3, 2, 2, 1, 3, 1, 1, 1, 2, 2, 10, 1, 
2, 1, 2, 2 
0.92 
90 7, 2, 2, 1, 5, 1, 15, 3, 2, 2 0.82 
85 9, 3, 6, 18, 2, 2 0.73 
80 12, 24, 4 0.55 
BOX-PCR: (GTG)5-
PCR      (6:1)  
95 2, 1, 2, 4, 3, 2, 3, 1, 1, 1, 2, 1, 2, 
2, 10, 1, 2 
0.92 
90 2, 1, 2, 7, 2, 4, 1, 1, 3, 15, 2 0.82 
85 3, 2, 9, 6, 18, 2 0.73 
80 5, 9, 24, 2 0.59 
*Clusters too numerous for calculation to be completed within the BioNumerics program.  
Similarity cut-off is the percent relatedness value used to define clusters.  Cluster size is the 
number of isolates comprising each cluster defined (differentiated by comma).  Discriminatory 
index calculated using Simpson's Diversity index 
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Repeatability 
Fig. 3.1 shows replicate images of isolates analyzed by PFGE, (GTG)5-PCR and 
BOX-PCR genotyping methods.  While no method was found to be 100% repeatable, 
both PFGE and (GTG)5-PCR had reproducibility values ≥0.8 (Table 3.2).  When the 
BioNumerics software was utilized for band identification and classification, repeatability 
of BOX-PCR was found to be low with a value of 0.4.  However, repeatability values for 
the same analysis increased to a mean value of 0.7 when band classification was 
manually modified based on visual assessment (data not shown).  In one instance, an 
isolate analyzed by PFGE appeared to exhibit an additional restriction site (Fig. 3.1A, 
lane 4).  Apart from this, all PFGE were reproducible. 
 
Table 3.2 
Repeatability of PFGE, (GTG)5-PCR and BOX-PCR in 
genotyping of M. haemolytica   
Method Isolate # Repeatability 
   
PFGE 235 1.0 
553 1.0 
616 0.8 
1335 1.0 
1358 1.0 
(GTG)5-PCR 235 0.8 
553 0.8 
616 0.8 
1335 0.8 
1358 0.8 
BOX-PCR 235 0.4 
553 0.4 
616 0.8 
1335 0.2 
1358 0.2 
Repeatability calculated as the proportion of isolates 
>95% similar based on UPGMA cluster analysis of 
Dice coefficients, n=5   
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Congruence and agreement between methods 
 The congruence and regression (r) values derived from the Kendall’s tau 
congruence analysis between PFGE, BOX-PCR and (GTG)5-PCR are presented in Table 
3.3.  The highest congruence was seen between PFGE and (GTG)5-PCR while the lowest 
was observed between the two rep-PCR methods.  All three congruence values scored a 
significance value >99.99 and standard deviation of ± 2.39.   
 
Table 3.3 
Congruence analysis between PFGE, (GTG)5-PCR and BOX-PCR genotypic analysis  
of  M. haemolytica 
 Congruence value  Regression plot r value 
Genotyping 
method PFGE 
(GTG)5-
PCR 
BOX-
PCR  PFGE 
(GTG)5-
PCR 
BOX-
PCR 
PFGE   29.8    0.61 
(GTG)5-PCR 39.0    0.65   
BOX-PCR  25.0    0.55  
All congruence values scored a significance >99.99 and had a standard deviation of ± 
2.39 
 
Isolates that clustered together (at a similarity value of >90%) across genotyping 
methods are indicated in Table 3.4.  In total there were three groups of isolates that 
clustered together in all three typing methods examined, including the three weighted 
variants of the combined matrix.  PFGE and (GTG)5-PCR analyses exhibited the most 
similar  cluster arrangement, an observation which is supported by the congruence 
analysis.  
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Table 3.4 
Cluster agreement between PFGE, GTG5 and BOX-PCR methods when compared 
against PFGE type   
Isolate  
GTG-5 
type 
PFGE 
type 
BOX 
type 
BOX:GTG5    
type      
(1:1) 
BOX:GTG5    
type      
(3:1) 
BOX:GTG5    
type        
(6:1) 
964A 3 1 19 15 16 3 
596C 5 1 10 12 14 11 
553A 1 2 18 17 17 17 
1432A 1 2 19 14 16 3 
1359A 2 3 5 2 4 1 
1358A 2 3 5 2 4 1 
235A 1 4 4 1 3 6 
243A 1 4 4 1 3 6 
932A 4 5 6 16 5 2 
482A 1 6 18 17 17 17 
1348A 8 7 8 8 10 13 
1346A 7 7 14 7 9 10 
1340A 5 8 8 8 10 13 
916A 5 9 15 5 7 8 
369A 6 10 1 3 1 4 
163A 6 10 2 4 2 5 
1332A 5 10 7 10 12 15 
863A 5 11 17 9 11 14 
1339A 5 12 7 10 12 15 
164A 6 13 2 4 2 5 
867A 5 14 13 9 11 14 
616A 5 14 11 13 15 12 
596A 5 14 7 10 12 15 
394A 5 14 7 10 12 15 
134A 5 14 7 10 12 15 
154A 5 14 7 10 12 15 
382A 5 14 9 12 12 16 
254A 5 14 9 12 14 11 
346A 5 14 1 3 1 4 
251B 5 14 1 3 1 4 
153A 6 14 3 4 2 5 
1064A 5 15 12 5 6 7 
1347A 9 16 7 11 13 15 
596B 5 17 7 10 12 15 
1333A 7 18 7 10 12 15 
936A 7 19 16 6 8 9 
1335A 5 20 7 10 12 15 
1046A 5 21 12 5 6 7 
1043A 7 21 12 5 6 7 
364A 6 22 1 3 1 4 
Similarity cut-off values were chosen based upon the lowest values that corresponded 
with a discriminatory value >90% in Table 1.  Blocks highlight isolates that show 
consistent clustering for multiple methods of analysis.  Numbers represent the cluster 
each isolate was grouped with within each method. 
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Species Identification 
 Dendrograms produced from cluster analysis of the reference strains by BOX-
PCR, PFGE and (GTG)5-PCR are presented in Fig. 2, Fig. 3, and Fig. 4, respectively.  
Banding patterns generated from the BOX-PCR contained between 7 and 25 bands 
ranging from 400 to 10,000 bp.  Banding patterns generated from (GTG)5-PCR contained 
between 15 and 23 bands ranging from 100 to 6,000 bp and PFGE produced between 8 
and 17 bands that ranged from 20.5 to1,135 kb.  BOX-PCR clustered all M. haemolytica 
strains together at a similarity value of 50% while PFGE did so at 36.6%.  Both BOX-
PCR and PFGE analyses clustered all M. haemolytica into a single group.  With the 
exception of one isolate, (GTG)5-PCR clustered M. haemolytica into one group with a 
relatedness of 79%.  BOX-PCR and (GTG)5-PCR also clustered M. glucosida and M. 
ruminalis isolates together.  
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Fig. 3.2. Dendrogram of BOX-PCR fingerprints created using UPGMA clustering of Dice coefficient values.  
Similarity matrix based on band-matching analysis, optimization and position tolerance settings of 1.00% and 
1.5% respectively. Sample assignments preceded by an F indicate M. haemolytica field isolates. 
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Fig. 3.3. Dendrogram of PFGE fingerprints created using UPGMA clustering of Dice coefficient values.  
Similarity matrix based on band-matching analysis, optimization and position tolerance settings of 1.00% 
and 1.5% respectively. Sample assignments preceded by an F indicate M. haemolytica field isolates. 
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3.4 Discussion 
 
Discriminatory power and repeatability  
The primary aim of this study was to compare the use of two rep-PCR techniques 
and PFGE for the molecular typing and speciation of M. haemolytica.  PFGE analysis is 
widely accepted as the gold standard for molecular typing and has previously been 
utilized with Pasteurellaceae species, including M. haemolytica (Gunawardana et al., 
2000; Katsuda et al., 2003; Kodjo et al., 1999; Villard et al., 2006).  Consequently, it was 
expected that PFGE analysis would perform well in comparison with the rep-PCR 
methods examined here.  Both (GTG)5-PCR and BOX-PCR have been applied to an array 
of species including acetic acid bacteria (De Vuyst et al., 2008), Bifidobacterium species 
(Masco et al., 2003), and Escherichia coli (Mohapatra et al., 2008), each claiming 
varying degrees of success.  However, these methods have not previously been applied to 
the study of M. haemolytica making the rep-PCR performance here more difficult to 
predict. 
Of the methods employed, (GTG)5-PCR displayed the lowest discriminatory 
power whereas PFGE exhibited the highest. To be considered reliable, a typing method 
should exhibit a discriminatory index greater than 0.9 (Hunter and Gaston, 1988).  Alone, 
(GTG)5-PCR analysis was less than this value; however, a composite fingerprint that 
combined both BOX-PCR and (GTG)5-PCR profiles was shown to increase the 
discriminatory index above this confidence threshold.  Previous studies examining both 
Listeria monocytogenes (Chou and Wang, 2006) and E.coli (Johnson and O'Bryan, 2000)  
have shown a similar increase in discriminatory indices when producing a combined 
analysis indicating the potential for improved discriminatory performance with the 
  62 
amalgamation of multiple typing methods.  However, our study showed that BOX-PCR 
analysis alone provides better discrimination than (GTG)5-PCR or a combination of 
(GTG)5-PCR and BOX-PCR.   
Although discriminatory power is often considered at the forefront when 
evaluating typing methods, repeatability of the procedure is equally important in 
determining its overall value. Generally, PFGE is considered a procedure with medium to 
high repeatability while rep-PCR is considered to have medium to low repeatability 
(Foxman et al., 2005).  Our results are consistent with this pattern, as PFGE was highly 
repeatable while (GTG)5-PCR and BOX-PCR exhibited low repeatability when used to 
genotype M. haemolytica.   
For BOX-PCR and (GTG)5-PCR, the majority of the error related to repeatability 
was caused by misidentification of bands by the BioNumerics software.  Reproducibility 
of rep-PCR techniques have previously been reported to be problematic (Johnson and 
O'Bryan, 2000) with qualitative difference in banding patterns highlighted as a specific 
problem (Gevers et al., 2001).  The latter issue was of a particular concern here with 
respect to the BOX-PCR results and to a lesser extent with the (GTG)5-PCR.  Although 
the rep-PCR banding patterns between replicate profiles were often visually identifiable 
as the same, variance in the intensity of the bands resulted in misidentifications when 
bands were identified using image analysis.  Visual identification of bands improved 
repeatability, in particular with BOX-PCR.  However, manual identification of bands 
negates time savings associated with these more rapid procedures and introduces the 
possibility of subjective bias.    
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In contrast to rep-PCR, individual PFGE profiles showed consistency in intensity.  
In the case of PFGE, the error in repeatability was due to a shifting in the band profile of 
one replicate isolate.  This resulted in the loss of one larger fragment with the subsequent 
appearance of two smaller fragments, indicating that the cause was most likely the result 
of a point mutation that created a new restriction site (Tenover et al., 1995).  Although 
plasticity in the genome of M. haemolytica has been reported (Villard et al., 2008), 
variation was not observed until after 15 or more repetitive subcultures.  In spite of this 
single incident, PFGE was still found to be a very repeatable procedure and even with the 
shifting in a single profile, an average repeatability value >95% was maintained. 
Congruence and agreement between methods 
 A low level of congruence was observed between the three techniques examined.  
Lack of agreement between typing methods has previously been documented (Weigel et 
al., 2004; Yokoyama et al., 2007) and should be expected as separate typing methods use 
different sources of genetic variation to produce genetic profiles (CLSI, 2007).  Low 
congruence between genotyping methods may allow for increasing discriminative 
capability by combining the methods (Yokoyama et al., 2007).  This mainly would be 
applicable to the rep-PCR methods, as they required less processing time, and both had 
lower discriminatory power compared to PFGE.  However, as mentioned above, there 
was no benefit to combining (GTG)5-PCR and BOX-PCR as the resulting discrimination 
did not increase to a value greater than that achieved by BOX-PCR alone.   
Species Identification 
Since the reclassification of the Mannheimia genus (Angen et al., 1999), few 
attempts have been made to develop molecular based methods to speciate this respiratory 
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pathogen.  Of the PCR –based identification assays available (Alexander et al., 2008a, b; 
Catry et al., 2004; Guenther et al., 2008) none are able to fully speciate M. haemolytica.  
This is mainly because little information is known about the genomes of other 
Mannheimia species.  In our study, both the PFGE and rep-PCR methods exhibited some 
capacity to separate isolates at the species level but only BOX-PCR was capable of 
clustering all species correctly.  Other studies have presented rep-PCR as a promising 
tool for identification at the species level (Gevers et al., 2001; Masco et al., 2003) and the 
results here support BOX-PCR for future use as a means of speciation of members of the 
Mannheimia genus.   
 In conclusion, based on discriminatory power and repeatability, PFGE was more 
effective than either BOX-PCR or (GTG)5-PCR at genotyping M. haemolytica.    
However, BOX-PCR was shown to provide important information in terms of 
discrimination and may hold potential for use in epidemiological study of M. haemolytica 
in feedlot cattle.  BOX-PCR was also shown to be the most effective means of speciation 
for members of the Mannheimia genus examined.  This study supports that rep-PCR 
holds potential as an alternative to PFGE, which was shown to be not only the most 
discriminating of the methods examined but also the most time consuming and costly. 
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CHAPTER FOUR 
 
Genetic characterization and antimicrobial susceptibility of Mannheimia haemolytica 
isolated from the nasopharynx of feedlot cattle in western Canada 
 
4.1 Introduction 
 
Bovine respiratory disease (BRD) is one of the most significant health problems 
facing the North American cattle industry.  Financial losses due to this condition exceeds 
the combined cost of all other diseases in cattle (Highlander, 2001) as a result of 
treatment costs, production losses and mortalities (Gagea et al., 2006; Larson, 2005; 
Snowder et al., 2006).  Estimates within the USA place losses between 640 million USD 
(Babcock et al., 2008; Bowland and Shewen, 2000; Snowder et al., 2007) and 3 billion 
USD annually (Snowder et al., 2007) but these values are in all likelihood 
underestimated.  Additional costs associated with increased labor, performance losses and 
reduced carcass value (Bateman et al., 1990; Encinias et al., 2006; Gagea et al., 2006; 
Larson, 2005) also add to economic losses associated with BRD.  The etiology of BRD is 
complex with its onset linked to a variety of environmental stressors associated mostly 
with the marketing and transport of cattle.  These include practices such as, weaning, 
castration, shipping, and co-mingling (Gagea et al., 2006) all of which are often executed 
just prior, or at the time that cattle first enter the feedlot.  Combined, these factors may 
compromise the immune system enabling viral and/or bacterial pathogens to become 
established in the respiratory tract and contribute to BRD (Cusack et al., 2003).  In most 
cases, illness is thought to be initiated by a viral agent, followed by a secondary bacterial 
infection that induces severe fibrinonecrotic pneumonia (Kehrenberg et al., 2001b; 
Whiteley et al., 1992). 
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Presently, Mannheimia haemolytica is considered the principal bacterial pathogen 
associated with BRD (Gioia et al., 2006; Katsuda et al., 2007; Rice et al., 2007; Welsh et 
al., 2004; Whiteley et al., 1992; Zecchinon et al., 2005).  Although significant 
information is available that addresses the pathogenic nature of M. haemolytica 
(Ackermann and Brogden, 2000; Highlander, 2001; Mohamed and Abdelsalam, 2008; 
Zecchinon et al., 2005) little is understood about the epidemiology of this pathogen 
within the feedlot setting.  Recent taxonomic amendments to the Mannheimia genera 
(Angen et al., 1999) have made works published previous to this time ambiguous about 
the taxa examined.  As a result, both epidemiological and long-term surveillance data 
exclusive to M. haemolytica is largely unavailable.   
Obtaining a better understanding of the ecology of M. haemolytica within the 
feedlot setting is necessary towards the development of an efficacious means of 
management.  To our knowledge no work has been conducted examining the genetic 
diversity or nature of antimicrobial resistance in M. haemolytica from cattle upon arrival 
and exit from feed yards.  The former is of considerable concern as a clear link has been 
established between strain type, particularly with regards to serotype A1, and its potential 
for pathogenicity (Highlander, 2001).  The latter is of equal significance as the 
development of antimicrobial resistance has implications for the efficacy of 
antimicrobials targeted at controlling BRD.  It is the objective of this work to provide 
epidemiological data that will aid in our understanding of the ecology of M. haemolytica 
within the feedlot sector.     
 
 
  67 
4.2 Materials and Methods 
 
Isolation and identification 
Nasal samples were collected from a subset of cattle (approximately 10% from 
10% of the pens) housed within two feedlots in the southern region of Alberta, Canada.  
Samples were taken from corresponding animals at arrival and within the same animals 
30 days prior to exit over a period spanning September 2008 to February 2009.  Samples 
were collected with commercially available deep-guarded culture swabs with a Cary-
Blair agar reservoir for transport (BD Canada, Inc., Mississauga, ON).  All samples were 
transported on ice to a central shipping location and stored at 4 °C for a period no longer 
than ten days prior to shipment on ice to a microbiology laboratory for analysis.  Upon 
receipt the samples were suspended in 0.7 ml of brain heart infusion (BHI) broth.  A 100 
µl aliquot of the suspension was cultured overnight at 37 °C on TSA plates containing 
5% sheep blood and 15 μg/ml of bacitracin (Dalynn Biologicals, Inc., Calgary, AB, 
Canada).  A maximum of three Mannheimia-like colonies (i.e. white-grey, round, 
medium sized, non mucoid, exhibiting haemolysis) were subcultured (conditions as 
above) from each plate and further tested for catalase and oxidase production.  Oxidase 
testing was performed using commercially obtained oxidase testing strips (Oxoid Canada, 
Inc., Nepean, ON) and catalase testing was conducted by combining a loop full of culture 
and approximately 10 µl of 3% hydrogen peroxide on a sterile glass slide.  A positive 
response for catalase testing was identified by the production of gas.  Those isolates that 
had typical M. haemolytica colony morphology and proved both catalase and oxidase 
positive were subsequently confirmed as M. haemolytica using a multiplex PCR assay 
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(Alexander et al., 2008b).  M. haemolytica isolates were stored at -80 °C in BHI broth 
containing 20% glycerol until further characterization was undertaken.   
Preliminary pulsed-field gel electrophoresis (PFGE) analysis was conducted on 
three isolates (maximum) obtained from each of a dozen randomly selected nasal 
samples, encompassing both arrival and exit samples.  The results revealed that colonies 
of M. haemolytica collected from the same plate were largely clonal (data not shown) or 
strongly related (>90% similar).  As a result, a single isolate from each nasal sample was 
used for further analysis within this study.   
Pulsed-field gel electrophoresis (PFGE) 
Preparation of DNA samples and pulsed-field gels adhered to the PulseNet USA 
protocols employed by the Centers for Disease Control and Prevention, Atlanta, USA 
(CDC, 1996).  Briefly, overnight blood agar cultures (16-18 h at 37 °C) of M. 
haemolytica were suspended in 2 ml of cell suspension buffer (0.1 M Tris; 0.1 M EDTA, 
pH 8.0) to an absorbance reading between 1.25 and 1.35 at a wavelength of 610 nm.  
Salmonella serotype Braenderup (H9812) was cultured overnight on Luria-Bertani agar 
then diluted to be within the same OD at 610 nm as for M. haemolytica and was used as a 
reference standard.  Agar plugs of each species were prepared from suspensions 
containing 10 µl of Proteinase K (20 ng/ml of sterile distilled H2O) combined with 100 µl 
of a culture suspension and 100 µl 1% SeaKem Gold agarose (in sterile TE, pH 8) (Lonza 
Canada, Inc., Shawinigan, QC) containing 10% sodium dodecyl sulphate (in sterile 
distilled H2O).  These were lysed in 5 ml of cell lysis buffer (0.05 M Tris pH 8.0, 0.05 M 
EDTA pH 8.0, 1% Sarcosyl) containing 25 µl of Proteinase K (20 ng/ml of sdH2O) at 54 
ºC and 100 rpm for 3 h.  The plugs were then washed twice with 10 ml of sterile ultra 
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pure water and four times with 10 ml of sterile 1xTE (10 mM Tris, 1mM EDTA, pH 8.0) 
for periods of 15 min at 54 ºC and 100 rpm.   M. haemolytica DNA was digested 
overnight at 37 º C with 10 U of SalI endonuclease and 180 µl of associated buffer that 
was supplied by the manufacturer (Invitrogen Canada, Inc., Burlington, ON).  The 
Salmonella serotype Braenderup size standards were digested overnight in a similar 
fashion with 10 U of XbaI endonuclease (Invitrogen Canada, Inc.).   
Fragments of DNA were separated by PFGE using the CHEF DRII apparatus 
(Bio-Rad Laboratories Canada, Ltd., Mississauga, ON) run at 6 V/cm at 12 °C with 
switch times of 4-40 s for 22 h.  Samples were loaded into 1% SeaKem Gold agarose 
(Lonza Canada, Inc., Shawinigan, QC) that had been dissolved in 0.5X TBE buffer and 
were run in the same manner with the addition of 0.5 mM thiourea to improve band 
compression.  The gels were stained with 1 µg/ml of ethidium bromide for 30 min 
followed by three washes in distilled water for the same duration and photographed on a 
UV transilluminator.  Fragment analysis was performed with BioNumerics V5.1 (Applied 
Maths, Inc., Austin, TX, USA).   M. haemolytica type strain 33396 (ATCC) was run with 
each group of isolates to serve as a reproducible standard for comparisons in 
BioNumerics.      
Antibiograms 
Disk susceptibility tests were conducted in accordance with the Clinical and 
Laboratory Standards Institute document M31-A (CLSI, 2007).  Reference strains 
Escherichia coli ATCC 35218, Staphylococcus aureus ATCC 25923, Streptococcus 
pneumoniae ATCC 49619 and M. haemolytica ATCC 33396 were used as quality 
controls.  Briefly, Muller-Hinton blood agar cultures (16-18 h at 37 °C) were suspended 
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into Muller-Hinton broth to an absorbance reading between 0.130 and 0.145 at 625 nm.  
The prepared inocula were swabbed onto Muller-Hinton blood agar plates using sterile 
swabs and antimicrobial charged disks were dispensed onto the plate surface.  The plates 
were incubated at 37 °C in ambient air, with the exception of S. pneumoniae ATCC 
49619 which required cultivation in a 5% CO2 atmosphere for 24 h.  The resulting zones 
of inhibition were read using the BioMic V3 imaging system (Giles Scientific, Inc., Santa 
Barbara, CA, USA).  The antimicrobials examined and their suppliers as well as the 
media and resistance breakpoints applied are listed in Table 4.1.  
 
Table 4.1 
 Antimicrobial agents, suppliers, disk contents and interpretative criteria used for disk susceptibility 
testing  
 
Code Supplier 
Disk 
Content             
(ug) 
Zone diameter 
breakpoints 
Antimicrobial S I R 
Amoxicillin/Clavulanic Acidd AMCL 
BD 
Biosciences 30 ≥27 n/a ≤26 
Sulfamethoxazole/trimethoprimb TMSZ Benex 23.75/1.25 ≥24 n/a n/a 
Ampicillina AMPI  
BD 
Biosciences 10 ≥27 n/a n/a 
Ceftiofura CTIO 
BD 
Biosciences 30 ≥21 18-20 ≤17 
Enrofloxacina ENRO 
BD 
Biosciences 5 ≥21 17-20 ≤16 
Florfenicola FLOR 
Mast 
Diagnostics 30 ≥19 15-18 ≤14 
Tulathromycina TULA  
Pfizer/ BD 
Biosciences 30 ≥18 15-17 ≤14 
Tilmicosina TILM 
BD 
Biosciences 15 ≥14 11-14 ≤10 
Gentamicinc GENT  
BD 
Biosciences 10 ≥15 14-13 ≤12 
Oxytetracyclineb OXYT Benex 30 ≥23 n/a n/a 
aM31-A2: Performance Standard for Antimicrobial Disk and Dilution Susceptibility Tests for 
Bacteria Isolated from Animals; Approved Standard- Second Edition 
bM45-A: Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently 
Isolated or Fastidious Bacteria; Approved Guideline 
cBioMic Vet General 
dBioMic Pasteurella 
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PCR 
PCR analysis of isolates exhibiting resistance was performed to determine the 
presence or absence of the determinants listed in Table 4.2.    Isolates exhibiting 
resistance to oxytetracycline were screened for six tet resistant genes whereas those 
exhibiting resistance to ampicillin and/or amoxicillin/clavulanic acid were screened for 
blaROB-1, blaOXA1, blaTEM-1 and blaPSE-1.  Isolates that exhibited macrolide resistance 
(tilmicosin and/or tulathromycin resistance) were screened for the presence of six erm 
genes. 
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Table 4.2 
Primer sequence, amplicon size, annealing temperature and gene accession numbers for resistance 
genes screen for by PCR 
Resistance 
gene PCR primer sequence 5'-3' 
Amplicon 
size 
Genbank 
accession No.a 
Annealing 
temp (°C) 
tetB TTGGTTAGGGGCAAGTTTTG 659 J01830 55 
 GTAATGGGCCAATAACACCG    
tetG GCTCGGTGGTATCTCTGCTG 468 S52437 55 
 AGCAACAGAATCGGGAACAC    
tetH ATACTGCTGATCACCGT 1076 Y16103 60 
 TCCCAATAAGCGACGCT    
tetK TCGATAGGAACAGCAGTA 169 S67449 55 
 CAGCAGATCCTACTCCTT    
tetL TCGTTAGCGTGCTGTCATTC 267 U17153 55 
 GTATCCCACCAATGTAGCCG    
tetM GTGGACAAAGGTACAACGAG 406 X90939 55 
 CGGTAAAGTTCGTCACACAC    
blaROB-1 AATAACCCTTGCCCCAATTC 685 X52872 60 
 TCGCTTATCAGGTGTGCTTG    
blaOXA-1 TCAACTTTCAAGATCGCA 591 N/a 56 
 GTGTGTTTAGAATGGTGA    
blaTEM-1 GTGCGGTATTATCCCGTGTT 416 N/a 58 
 AACTTTATCCGCCTCCATCC    
blaPSE-1 CGCTTCCCGTTAACAAGTAC 419 M69058 60 
 CTGGTTCATTTCAGATAGCG    
ermA GAAATYGGRTCAGGAAAAGG 332 X03216 55 
 AAYAGYAAACCYAAAGCTC    
ermB GATACCGTTTACGAAATTGG 364 X52632 58 
 GAATCGAGACTTGAGTGTGC    
ermC TCAAAACATAATATAGATAAA 642 M19652 50 
 GCTAATATTGTTTAAATCGTCAAT    
ermF CGACACAGCTTTGGTTGAAC 309 M14730 56 
 GGACCTACCTCATAGACAAG    
ermT CATATAAATGAAATTTTGAG 369 AF310974 51 
 ACGATTTGTATTTAGCAACC    
ermX GAGATCGGRCCAGGAAGC 488 X51472 58 
  GTGTGCACCATCGCCTGA       
an/a, not available    
 
Isolates used for DNA extraction were cultured overnight at 37 °C on blood agar 
plates.  Genomic DNA was purified using the DNeasy Tissue Kit (Qiagen Canada, Inc., 
Mississauga, ON) according to the manufacturer’s instructions with slight modification to 
the procedure.  Lysis was extended overnight at 4 °C and the final elution steps were 
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reduced to 180 µl to concentrate the product.  Genomic DNA was diluted to 5 ng/µl with 
sterile TE (pH 7.4) and stored at -20 °C until use.  
All PCR reaction mixtures (20 µl) contained (final concentrations): 1X 
HotStarTaq Plus Master Mix (Qiagen Canada, Inc.), 2.0 µM primer and 1X CoralLoad 
Concentrate (Qiagen Canada, Inc.).  Two microlitres of purified 5 ng/µl DNA was used 
as template and all PCR amplifications were performed using an Eppendorf Mastercycler 
(Eppendorff Canada, Ltd., Mississauga, ON) with the following conditions: 95 °C for 5 
min; 30 cycles of 94 °C for 30 s, variable annealing temp (refer to Table 4.2) for 1 min 
and 72 °C for 1 min; and 72 °C for 8 min.   
A modification of the above program was used for erm genes where a touchdown 
assay was applied as described by Chen et al. (2007).  The program consisted of an initial 
activation step of 95 °C for 5 min, followed by five cycles of touchdown PCR involving: 
94 °C for 30 s, 30 s of annealing temp beginning at 5 °C above the final annealing 
temperature (Table 4.2) with a 1 °C decrement for each cycle, and extension at 72 °C for 
1 min.  The five touchdown cycles were followed by regular PCR: 35 cycles of 94 °C for 
30 s, respective annealing temperatures (Table 4.2) for 30 s and 72 °C for 1 min; and 72 
°C for 8 min. 
Statistical analysis 
All PFGE related statistical analyses were performed using BioNumerics V5.1 
software (Applied Maths, Inc., Austin, TX, USA).  Dendrogram analysis used UPGMA 
clustering of Dice coefficient values with 1.0 % optimization and 1.5 % position 
tolerance settings.  MANOVA analysis was calculated from a binary band-matching 
character table constructed from the 44 band classes originally identified from the 
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individual isolate banding profiles.  The four categories used for analysis corresponded to 
the four sampling categories defined (feedlot A and feedlot B, arrival and exit samples) 
and accounting for covariance was selected within the BioNumerics software.         
 The Fisher’s exact test was used to determine the significance of disparity found 
in the prevalence of M. haemolytica between arrival and exit samples from feedlots A 
and B. 
 
4.3 Results 
 
Prevalence data  
A total of 2487 bovine nasal swabs were processed during the study period (Table 
4.3).  Recovery of M. haemolytica from nasal swabs was similar between the two 
feedlots, with just over 16 % of the samples being positive.  In feedlot B, the prevalence 
of M. haemolytica was higher (P <0.005) in exit samples (20%) than arrival (13.16%) 
samples. The highest recovery rate of M. haemolytica was 20% (feedlot B exit) and the 
lowest was 13.6% in arrival samples from feedlot B.     
 
Table 4.3 
Prevalence of M. haemolytica  
  
No. nasal samples     
processed 
No. nasal samples positive for M. haemolytica 
(%) 
Fisher's 
Exact Test 
2-Tail          
(p-value) Feedlot arrival exit total arrival exit total 
A 605 595 1200 105 (17.36) 98 (16.48) 203 (16.92) 0.762 
B 669 618 1287 88 (13.16) 125 (20.23) 213 (16.56) 0.005 
Total 1274 1213 2487 193 (15.15) 223 (18.39) 416 (16.73) 0.072 
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PFGE Total Data Set 
 PFGE typing and cluster analysis revealed considerable diversity within the M. 
haemolytica isolates obtained.  Of the 414 isolates genotyped, a total of 313 unique 
pulsotypes were detected (Table 4.4).  When the similarity cut-off was set at 85%, 
analysis revealed 148 clusters of related isolates within the total data set.  A high level of 
diversity was observed from all four classifications (feedlot A and B, arrival and exit) and 
the average cluster size was low (1.91-2.8).   
 
Table 4.4 
Results of M. haemolytica PFGE analysis 
      similarity cut-off 85% 
  
No. 
isolates 
No. unique 
pulsotypes 
No. 
Clusters 
Ave. No. of isolates 
per cluster (±SD) 
Range of isolates 
per cluster 
Feedlot A & B 414 335 148 2.80 (3.72) 1-27 
Feedlot A 203 171 96 2.14 (2.88) 1-26 
arrivals 106 95 49 2.15 (2.86) 1-20 
exits 97 83 48 1.95 (2.65) 1-16 
Feedlot B 211 187 95 2.22 (2.26) 1-12 
arrivals 82 72 43 1.91 (2.09) 1-10 
exits 129 119 71 1.82 (1.65) 1-9 
 
Dendrogram analysis of all isolate profiles identified three main clusters (A, 97 
isolates; B, 288 isolates; C, 24 isolates) with divergence at 46.4 %, 48.3% and 61.7%, 
respectively (Fig. 4.1). A total of five isolates were observed as outliers from the three 
main groups. Nodes were strategically collapsed with the intention of maintaining the 
general structure of the dendrogram while at the same time condensing the figure into a 
manageable size. Visual comparison revealed no clear trend in cluster composition based 
upon sampling classification.  Of the six largest clusters identified, five contained 
samples from each of the four sample classifications while the remaining cluster was 
comprised mostly of M. haemolytica from arrival cattle sampled at feedlot A. 
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Fig. 4.1. Dendrogram based on PFGE analysis of M. haemolytica isolates recovered from bovine nasal swabs 
collected from two feedlots in southern Alberta, Canada, from 2008 to 2009. Dendrogram (shown here in simplified 
form) was constructed from UPGMA clustering of Dice coefficient values, optimization 1.0% and position tolerance 
1.5%.  Triangles represent arborizing subclusters and boxes to the right show the proportion each sampling 
classification contributed to each subcluster.  Three main subclusters labeled A, B and C dominated the expanded 
form and are comprised of 97, 288 and 24 isolated respectively. 
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MANOVA analysis was used to create a spatial representation of the degree of 
separation and/or overlap of the isolates grouped within each feedlot, across each time 
point (Fig. 4.2).  The first two discriminates accounted for 85.9% of the total 
discrimination.   Probability values for the first two discriminates were each ≤0.02 and 
the L (Wilk’s Lambda likelihood ratio test) for each was 0.40 and 0.69 respectively.  No 
distinct segregation was observed between each of the groups plotted (feedlot A and B, 
arrival and exit).  However, in general, the exit groups from both feedlots demonstrated a 
higher degree of spread versus the arrival isolates which tended to cluster towards the 
center of the plot.   
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.2.  MANOVA of PFGE fingerprints from M. haemolytica isolates 
obtained from bovine nasal swabs.  Binary band-matching character tables 
were analyzed by MANOVA, accounting for the covariance structure.  
Isolates were categorized into arrival versus exit sample from two feedlots, 
A and B.    
A arrival
A exit
B arrival
B exit
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 In twenty-four instances (12 from each feedlot) M. haemolytica was recovered 
from an animal at both arrival and exit.  All other animals were positive for M. 
haemolytica at either arrival or exit, but not both.  Cluster analysis of these twenty-four 
cases revealed modest relationships, clonal or otherwise.  Of the twenty-four examined, 
only in three instances were the isolates collected at arrival and exit clones (Fig. 4.3).   
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Fig. 4.3. Dendrogram of PFGE profiles from M. haemolytica isolates collected from corresponding animals 
at arrival and exit from feedlot A and feedlot B.  Dendrogram created using UPGMA clustering of Dice 
coefficient values.  Similarity matrix based on band-matching analysis, optimization and position tolerance 
settings of 1.00% and 1.5%, respectively. 
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Antibiogram Data 
 Antimicrobial resistance in M. haemolytica was found to be consistently low for 
all of the antimicrobials examined, ranging from 0.8 to 7.8% (Table 4.5).  Complete 
susceptibility was observed for sulfamethoxazole/trimethoprim, ceftiofur, enrofloxacin, 
florfenicol and gentamicin.  In total, 42 isolates exhibited resistance to at least one of the 
antimicrobials tested (Table 4.6).  This represented 10.3% of the total number of M. 
haemolytica isolates collected.  Resistance to a single antimicrobial was most common 
with resistance to oxytetracycline (n=16), ampicillin (n=10), amoxicillin/clavulanic acid 
(n=7) and tulathromycin (n=3) being observed.  Six isolates exhibited resistance to more 
than one antimicrobial, 3 were resistant to ampicillin and amoxicillin/clavulanic acid, 2 
were resistant to oxytetracycline and amoxicillin/clavulanic and 1 exhibited intermediate 
resistance to both tilmicosin and tulathromycin.  There were no obvious trends in the 
nature of resistance in isolates obtained from different feedlots or at arrival or exit.   
Antimicrobial Usage Data 
 Approximately 40% and 48.7% of the M. haemolytica isolates from feedlot A 
and feedlot B, respectively originated from animals administered an injectable 
antimicrobial agent.  In almost all cases, oxytetracycline was administered; usually over 
two injections within 1-14 days after arrival at the feed yard.  At both feedlots, ceftiofur 
and tulathromycin were most commonly administered subsequent to the use of 
oxytetracycline.  Of the isolates in this study that expressed antimicrobial resistance 
phenotypes, less than half originated from cattle that were treated with injectable 
antimicrobials at the feedlot.  Of those that received treatment, five showed correlation 
between the treatment administered and resistance phenotype.  
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Table 4.5      
Antimicrobial resistance in M. haemolytica recovered from bovine nasal swabs 
  % antimicrobial resistance 
 feedlot A feedlot B  
  
arrival    
(103) 
exit            
(97) 
arrival       
(80) 
exit       
(129) 
Total      
(409) 
Amoxicillin/Clavulanic Acid 4.9 2.1 1.3 1.6 2.4 
Sulfamethoxazole/trimethoprim 0.0 0.0 0.0 0.0 0.0 
Ampicillin 4.9 4.1 6.3 0.8 3.7 
Ceftiofur 0.0 0.0 0.0 0.0 0.0 
Enrofloxacin 0.0 0.0 0.0 0.0 0.0 
Florfenicol 0.0 0.0 0.0 0.0 0.0 
Tulathromycin 0.0 1.0 2.5 0.8 1.0 
Tilmicosin 0.0 1.0 0.0 0.0 0.2 
Gentamicin 0.0 0.0 0.0 0.0 0.0 
Oxytetracycline 7.8 3.1 1.3 4.7 4.4 
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Table 4.6   
Resistance profiles, gene determinants and antimicrobial treatment records for M. haemolytica field isolates 
expressing resistance phenotypes 
Isolate  Feedlot 
Sampling 
event 
AMR 
profilea 
AMR 
genesc 
Enrolment 
date Exit date 
Treatment 
dated 
Treatment    
(mg/kg)e 
143A B Arrival AMP n/d 3-Oct-07 18-Jan-08 n/t n/t 
239A B Arrival AMP n/d 17-Oct-07 27-Mar-08 17-Oct-07 oxy-30  
       17-Oct-07 oxy-30  
240A B Arrival AMP n/d 17-Oct-07 27-Mar-08 17-Oct-07 oxy-30  
       17-Oct-07 oxy-30  
235A B Arrival TULA n/d 17-Oct-07 27-Mar-08 17-Oct-07 oxy-30  
       17-Oct-07 oxy-30  
364A B Arrival 
AMP, 
AMCL n/d 25-Oct-07 no sample n/t n/t 
369A A Arrival AMP n/d 25-Oct-07 09-May-08 16-Feb-08 ceft-1  
       17-Feb-08 ceft-1  
       18-Feb-08 ceft-1  
       02-Nov-07 oxy-20 
       25-Oct-07 oxy-30  
376A B Arrival AMP n/d 25-Oct-07 03-Apr-08 18-Nov-07 tula-2.5 
398A A Arrival 
AMP,  
AMCL n/d 26-Oct-07 09-May-08 02-Nov-07 oxy-20 
       26-Oct-07 oxy-30  
410A A Arrival AMCL n/d 28-Oct-07 08-May-08 06-Nov-07 oxy-20 
        28-Oct-07 oxy-30  
492A A Arrival 
AMP,  
OXYT blaROB-1 
10-Nov-
07 28-Mar-08 17-Nov-07 oxy-20 
        10-Nov-07 oxy-30  
501A A Arrival 
AMP,  
OXYT blaROB-1 
10-Nov-
07 14-Apr-08 17-Nov-07 oxy-20 
        10-Nov-07 oxy-30  
511C B Arrival OXYT tet(H) 
15-Nov-
07 29-May-08 15-Nov-07 oxy-30  
553A B Arrival TULA n/d 3-Dec-07 20-Feb-08 n/t n/t 
585A B Exit OXYT tet(H) 29-Sep-07 3-Jan-08 n/t n/t 
611A A Exit OXYT tet(H) 24-Sep-07 18-Jan-08 n/t n/t 
667A B Exit OXYT n/d 10-Oct-07 12-Feb-08 n/t n/t 
894A B Exit OXYT n/d 
10-Dec-
07 16-Mar-08 n/t n/t 
932A B Exit OXYT tet(H) 15-Oct-07 13-Mar-08 15-Oct-07 oxy-30  
       15-Oct-07 oxy-30  
953A A Exit AMP n/d 16-Oct-07 18-Mar-08 25-Oct-07 oxy-20 
         16-Oct-07 tula-2.5 
956A B Exit OXYT tet(H) 24-Oct-07 18-Mar-08 n/t n/t 
1040A B Exit AMP n/d 17-Oct-07 27-Mar-08 17-Oct-07 oxy-30  
       17-Oct-07 oxy-30  
1059A A Exit 
TILMb, 
TULAb erm(X) 11-Oct-07 28-Mar-08 19-Oct-07 oxy-20 
       11-Oct-07 oxy-30  
1243A B Exit AMCL n/d 25-Jan-08 15-Apr-08 25-Jan-08 oxy-20 
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       25-Jan-08 oxy-20 
1316A A Exit AMCL n/d 31-Oct-07 18-Apr-08 06-Nov-07 oxy-20 
       31-Oct-07 oxy-30  
1329A A Arrival AMCL n/d 25-Apr-08 03-Jul-08 n/t n/t 
1339A A Arrival 
AMP,  
AMCL n/d 25-Apr-08 03-Jul-08 n/t n/t 
1347A A Arrival AMCL n/d 25-Apr-08 03-Jul-08 n/t n/t 
1349A A Arrival OXYT tet(H) 25-Apr-08 03-Jul-08 n/t n/t 
1355A A Arrival OXYT tet(H) 26-Apr-08 10-Jul-08 n/t n/t 
1358A A Arrival OXYT tet(H) 26-Apr-08 10-Jul-08 n/t n/t 
1359A A Arrival OXYT tet(H) 26-Apr-08 10-Jul-08 n/t n/t 
1365A A Arrival OXYT tet(H) 26-Apr-08 10-Jul-08 n/t n/t 
1425A A Exit OXYT tet(H) 21-Feb-08 07-May-08 21-Feb-08 oxy-20 
1500A A Exit AMP n/d 26-Oct-07 09-May-08 02-Nov-07 oxy-20 
       26-Oct-07 oxy-30  
1548A A Arrival OXYT tet(H) 
16-May-
08 22-Jul-08 n/a n/a 
1719A B Exit AMCL n/d 
10-Dec-
07 19-Jun-08 n/a n/a 
1731A B Exit TULA n/d 1-Mar-08 19-Jun-08 n/a n/a 
1745A A Exit AMP n/d 11-Apr-08 20-Jun-08 n/a n/a 
1828A A Exit AMCL n/d 25-Apr-08 03-Jul-08 n/a n/a 
1829A A Exit AMP n/d 25-Apr-08 03-Jul-08 n/a n/a 
1886A A Exit OXYT tet(H) 2-May-08 07-Jul-08 n/a n/a 
5450A B Exit OXYT n/d 09-Oct-08 25-Feb-09 n/a n/a 
aAMP, ampicillin; AMCL, amoxicillin-clavulanic acid; OXYT, oxytetracycline; TILM, tilmmicosim; TULA, 
tulathromycin 
bintermediate resistance 
cn/d, gene not detected 
dn/a, data not available; n/t, animal not treated 
eoxy-03, oxytetracycline 30 mg/kg; oxy-20, oxytetracycline 20 mg/kg; ceft-1, ceftiofur 1 mg/kg; tula-2.5, 
tulathromycin 2.5 mg/kg 
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PCR Analysis 
PCR analysis showed that the majority of the oxytetracycline resistant isolates 
harboured the tetH gene.  The two isolates that tested negative for tetH were also negative 
for all of the tet genes that were screened (tetB, tetG, tetK, tetL, tetM).  Of the four 
macrolide resistant isolates screened, the isolate that showed intermediate resistance for 
both tilmicosin and tulathromycin was the only one positive for ermX.  The rest were 
negative for all of the six erm genes screened.  None of the resistance determinants 
examined were detected in the amoxicillin/clavulanic acid resistant isolates and of the 
isolates showing ampicillin resistance only two were positive for blaROB-1. 
PFGE Resistant Isolates 
 There was no apparent relationship between antimicrobial resistance, sampling 
location or sampling time of resistant isolates (Fig. 4.4).  Resistant isolates were shown to 
be diverse with the two main groups (A, ampicillin and amoxicillin/clavulanic acid 
resistant isolates and B, oxytetracycline resistant isolates) exhibiting a 40% relatedness.    
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4.4 Discussion 
 
Longitudinal surveillance data focusing on the genetic diversity of M. 
haemolytica in feedlot cattle is largely absent from the literature.  It was the intention of 
this study to document the prevalence and diversity of M. haemolytica found in feedlot 
cattle housed in two feed yards located in the southern region of Alberta, Canada and to 
investigate the effect antimicrobial use has on the subsequent development and spread of 
antimicrobial resistance in this important bovine pathogen. 
PFGE  
The data from this study revealed an impressive amount of genetic diversity in the  
M. haemolytica isolates examined both within and between feedlots.  In western Canada, 
the average truck load arriving at a feed yard can average 60 calves sourced from as 
many as 20 to 30 different farms (Ribble et al., 1995c).  This would account for the 
genetic variation observable in arrival samples, but the amount of genetic diversity 
observed among the exit samples is an inexplicable finding.  The propensity of the M. 
haemolytica genome to be both plastic (Kodjo et al., 1999; Villard et al., 2008) and 
adaptable (Davies et al., 2001; Larsen et al., 2009; Rowe et al., 2001) has been previously 
established and may provide basis for the significant diversity observed over the duration 
of the sampling period but does not explain the lack of observable dissemination of 
genotypes over the sample period.  Although previous work employing PFGE for 
genotypic analyses of M. haemolytica collected from cattle is limited, a single study 
conducted by Katsuda et al. (2003) did show a similar level of diversity in M. 
haemolytica serotype A1 isolates collected from cattle across locations in Japan.     
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There was no clear association detected between pulsotypes and sampling 
location in our study. On multiple occasions, clonal or strongly related isolates were 
recovered from both feedlots and across both sampling times, indicating a high degree of 
dispersion of  
M. haemolytica strains within this study region.  Other accounts examining M. 
haemolytica collected from multiple locals have documented a similar lack in correlation 
been origin and molecular subtype (Katsuda et al., 2003; Villard et al., 2006).  For this 
particular study, some of the commonality observed between feedlots could be attributed 
to both feed yards from a common stocking source such as an auction mart.   
It is acknowledged that a more ideal sampling point for arrival samples would 
have occurred around ten days after the calves arrived within the feed yard environment.  
This would allow the opportunity for dissemination of M. haemolytica to occur among 
animals and would coincide with the typical period where respiratory infection is 
observed to most frequently occur.  Unfortunately this approach was not feasible for use 
in a study of this scale.     
Out of a total of 413 samples, only in twenty- four cases occurred where M. 
haemolytica was recovered from individuals both at arrival and upon exit from the 
feedlots, suggesting that M. haemolytica may not persist in the nasal cavity of cattle 
throughout the feeding period or that a large number of the calves acquire this bacterium 
post-arrival.  There is currently no data available regarding the persistence of M. 
haemolytica within feedlot cattle.  However, its capacity for long term survival in vivo 
(Rowe et al., 2001) and its ability to persist in spite of prophylactic treatment in bighorn 
sheep (Weiser et al., 2009) has been previously documented and speaks towards its 
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potential for persistence.  Genotypic analysis of the correlated arrival/exit cases revealed 
little incidence of clonality between isolates collected from each sampling point.  Of the 
twenty- four cases identified only in three were the arrival and exit samples clones, with 
the remainder of arrival and exit samples exhibiting considerable diversity.   These 
findings, in combination with the substantial number of exit cases that show no 
corresponding infection at arrival, imply that the feed yards themselves may be a 
potential source of M. haemolytica.   
Given the animal-to-animal variation observed in pulsotypes, clonal spread of M. 
haemolytica throughout the feedlots examined appears to be limited.  This finding is 
counter intuitive from what is expected if the feedlot environment were acting as a source 
of M. haemolytica.  One potential explanation for this was touched upon above.  It is 
possible that acquisition of M. haemolytica is sporadic and inconsistent, and is being 
derived from an environmental community.  There is also the potential that some of the 
diversity observed is a product of divergence of M. haemolytica.   Previous work 
conducted in the laboratory has documented the apparent instability of the M. 
haemolytica genome (Villard et al., 2008), but it is not known if this elasticity in the 
genome of M. haemolytica is retained in vivo.  In our study, the duration between 
sampling periods (arrival to exit) was between three and six months.  It is unclear if this 
amount of time, given the presence of in vivo selective pressure, would be adequate to 
account for the highly diverse nature of the isolates obtained.  Further work that 
correlates the origin of incoming cattle with pulsotypes from cattle within the feed yard 
and those that examine the environmental and in vivo stability/persistence of M. 
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haemolytica over time may provide further insight into the origin of the genetic diversity 
observed.   
Antimicrobial resistance 
 Currently, antimicrobial agents present the most effective tool available for 
control of respiratory infections in cattle (Kehrenberg et al., 2001b).  As a result, the 
development of antimicrobial resistance in response to antimicrobial use is of concern.  
The results of this study reveal low levels of antimicrobial resistance in M. haemolytica , 
implying that at present the development and spread of resistance in M. haemolytica in 
response to antimicrobial use is low.  Recent publications by Catry et al. (2005) and 
Hendricksen (2008) report similarly low levels of resistance in M. haemolytica and the 
majority of the literature reflects the same general trends in resistance phenotypes with a 
trend towards resistance to tetracycline (Berge et al., 2006; Catry et al., 2007; Henricks et 
al., 1992; Post et al., 1991; Watts et al., 1994), ampicillin (Catry et al., 2007; Hendriksen 
et al., 2008; Post et al., 1991; Schwarz et al., 2004; Watts et al., 1994) and sulfa drugs 
(Hendriksen et al., 2008; Post et al., 1991; Watts et al., 1994) with a high level of  
susceptibility to ceftiofur (Berge et al., 2006; Catry et al., 2007; Hendriksen et al., 2008; 
Schwarz et al., 2004) and florfenicol (Berge et al., 2006; Catry et al., 2007; Schwarz et 
al., 2004).      
 Scrutiny of the antimicrobial resistant pulsotypes revealed no observable link with 
resistance phenotype.  There were very few instances of clonal spread observed either 
within or between feedlots and multiple occurrences of closely related isolates that 
exhibited dissimilar resistant phenotypes.  Further, there was a lack of relationship 
exhibited between isolates harbouring identical resistance determinants.  These findings 
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indicate that the resistance genes detected here are likely located on transferable 
elements.  This is consistent with previous reports that claim most resistance genes in M. 
haemolytica are found on small plasmids or transposons (Kehrenberg et al., 2001b).   
PCR 
Tetracyclines have been reported to account for almost two-thirds of the 
antimicrobials used in prophylactic treatment (Kehrenberg et al., 2001a).  This is 
consistent with what was reported here as the vast majority of antimicrobial usage in both 
feedlots consisted of the administration of oxytetracycline within 1-14 days of arrival into 
the feed yards.  Not surprisingly, oxytetracycline resistance was the most frequently 
observed phenotype expressed by the resistant isolates identified.  The tetH gene was the 
major allele detected from those isolates exhibiting oxytetracycline resistant phenotypes 
which is consistent with previous findings (Highlander, 2001). Based upon what was 
observed here, the lack of apparent diversity in tetracycline resistant alleles in 
combination with a lack of clonal spread of the resistant isolates implies that horizontal 
transfer may be the potential mechanism for spread of oxytetracycline resistance within 
each of these feedlots.         
  Next to oxytetracycline resistance, the most frequently observed resistant 
phenotypes were to ampicillin and amoxicillin/clavulanic acid.  Because neither of these 
antimicrobials were used in either of the feedlots studied, it is suspected that these 
isolates may have already harboured resistance upon entry.  The maintenance of 
resistance to both drugs from arrival through to exit was unexpected given the lack of an 
obvious selective pressure.  The blaROB-1 gene was the only determinant detectable from 
any of the ampicillin or amoxicillin/clavulanic acid resistant isolates.  It was found in two 
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oxytetracycline/ampicillin resistance isolates that originated from same group of cattle 
that arrived at the same time in one feedlot.  Interestingly these isolates were not strongly 
related based upon PFGE pulsotype and this phenotype did not appear to persist, as it was 
not detected in any of the exit samples.  Further genetic characterization of the resistance 
determinants detected here is required to comment on their rate of development and 
spread.   
 In conclusion, PFGE analysis revealed a significant amount of genetic diversity in 
the M. haemolytica isolates examined, both within and between feedlots.  Clonal spread 
throughout the feed yards appeared to be limited.  A low incidence of antimicrobial 
resistance was detected with the antimicrobial panel utilized here, implying that at 
present, the development and spread of resistance in M. haemolytica in response to 
antimicrobial use within the feedlots was low.  Further studies are necessary to determine 
if the results reported here are representative of what is occurring in M. haemolytica 
populations in other feedlots across North America. 
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CHAPTER FIVE 
 
Conclusions and Prospects 
 
 
Despite the current knowledge surrounding the condition, BRD continues to be a 
significant problem for cattle producers in North America. In the U.S.A., BRD is 
considered to be the most costly disease to beef cattle (Snowder et al., 2006).  In western 
Canada, it is reported that 10-30% of all auction market derived cattle are treated for 
BRD, with the overall mortality observed between two and four percent (Booker et al., 
2008).  Bearing in mind that Mannheimia haemolytica is identified as a primary bacterial 
agent in association with BRD (Rice et al., 2007), it is startling how little is understood 
about the dynamics of this pathogen within the feedlot setting.  Particularly in Alberta 
which boasts the fifth largest cattle feeding area in North America and sources roughly 
40% of the 17.3 million head comprising Canada’s national cattle and calf inventories 
(ABP, 2009).  
Antimicrobial therapies are the primary tool used for management of BRD.  Over 
80% of the antimicrobials licensed for use in cattle are directed against agents associated 
with BRD (Bowland and Shewen, 2000).  Because of this, pathogens such as M. 
haemolytica are possible high-risk targets for the development and spread of 
antimicrobial resistance.  The primary objectives of this work were to 1) characterize and 
document the genetic diversity of M. haemolytica present in two feedlots in southern 
Alberta and 2) to examine the potential effects antimicrobial usage within these 
environments might have on the development and spread of antimicrobial resistance 
within populations of this important veterinary pathogen.    
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Over the duration of this study, 2487 cattle nasal swab samples were processed 
and screened for the presence of M. haemolytica.  Although recovery values ranged from 
13-20%, the average prevalence from both collection sites, over both sampling times 
averaged 16%.  Data relevant to the current prevalence of M. haemolytica in Canadian 
feedlots is largely unavailable.  More information, similar in kind to what is presented 
here, is needed in order to help reveal the specific role M. haemolytica plays in the 
overall condition of BRD within feedlots.   
PFGE analysis was used to genetically fingerprint 414 M. haemolytica isolates.  
The percentage of unique pulsotypes from the total number of isolates examined was well 
above 80%, showing a significant amount of diversity.  What’s more, this level of 
diversity was consistently high when examining each sampling classification (each 
feedlot A and B, at either arrival or exit).  This finding is interesting because although it 
was initially suspected that the diversity between feedlots would be high, it was felt that 
within each location, the diversity observed would be moderate due to the effects of 
clonal spread. A great deal of the genetic diversity observed in arrival samples was in no 
doubt due to various stocking sources that are combined at market to contribute to each 
load of calves trucked to the feedlots.  However, the rational behind the genetic diversity 
observed in the exit samples remains elusive.    
Based upon the findings here, clonal spread of M. haemolytica throughout both 
feedlots examined was limited. On multiple occasions, clonal or strongly related isolates 
were recovered from both feedlots and across both sampling times, indicating a high 
degree of dispersion.    For this study, much of the commonality observed between 
feedlots might be attributed to the continuing stream of influx cattle from potentially 
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common stocking sources or might somehow be linked to the proximity of the feed yard 
to one another as they were within a 50 km radius of one another.  To determine if the 
results here are the by-product of the dynamics of M. haemolytica populations within the 
feedlot environment or the by-product of a limited geographic region of study, future 
work correlating the origin of incoming cattle with pulsotypes from cattle already housed 
within the feed yard would be beneficial.  Also, collection of  isolates from a more 
expansive and/or distant regions would serve to give a clearer picture about the overall 
diversity of the M. haemolytica populations in North America and how they might move 
throughout the beef production cycle.   
Although PFGE is considered to be the paragon for molecular typing it has some 
limitations with regards to its long turnaround time and requirement for expensive, 
specialized equipment.  As a consequence, rep-PCR methods BOX-PCR and (GTG)5-
PCR were applied to a subset of M. haemolytica isolates and Mannheimia spp. reference 
strains to examine the potential for application of rep-PCR in alternative.  As was 
hypothesized, against rep-PCR techniques, PFGE analysis was shown to be the most 
appropriate method with regards to discriminatory power and repeatability.  However it 
was also discovered that BOX-PCR may hold significant potential as a less time 
consuming and less costly alternative to PFGE analysis for speciation of the Mannheimia 
genera.  It is hoped that the availability of fast and inexpensive methods for genetic 
analysis will result in a higher incidence of larger scale genotypic investigations of M. 
haemolytica and Mannheimia spp.  Future genomic sequencing of Mannheimia species 
will hopefully allow for improved primer selection resulting in the increased value of rep-
PCR methods for speciation of this genus.     
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Disk susceptibility testing was conducted to determine the antimicrobial 
resistance profiles of the M. haemolytica isolates studied.  This method was cost effective 
and allowed for the efficient testing of many antimicrobial compounds simultaneously.  
Consistent with recent reports (Catry et al., 2005; Hendriksen et al., 2008) the results here 
revealed low incidence of antimicrobial resistance in the M. haemolytica examined.  This 
implies that at present, the development and spread of resistance in M. haemolytica in 
response to antimicrobial use within the feedlots is low, suggesting that the use of 
antimicrobial therapy within the feedlot setting may present minimal risk toward the 
development of antimicrobial resistance.  It is important to take into account that 
although the antimicrobials selected for examination in this study were chosen to 
represent those currently used for treatment, they do not encompass all the drugs utilized.  
It is also important to consider that antimicrobial resistance can develop in bacteria that 
are associated with cattle other than M. haemolytica, many of which can produce and 
transfer mobile genetic elements.  Regardless, the use of antimicrobial therapy is the 
primary tool against respiratory disease in cattle and the findings here support their 
continued use.  However, it is the opinion of the author that continued surveillance of 
antimicrobial resistance in the feedlot populations of M. haemolytica would be prudent.      
Of the resistance phenotypes detected, the most abundant was resistance to 
oxytetracycline followed by ampicillin resistance and then amoxicillin/clavulanic acid 
resistance.  A few cases of multi-drug resistance were detected but in general its 
occurrence was uncommon.  PCR analysis for a select number of known tetracycline 
determinants revealed the majority of oxytetracycline resistant isolates to harbour the 
tet(H) gene.  This is consistent with previous findings that report this to be the most 
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commonly found tet allele in M. haemolytica  (Highlander, 2001).  The majority of the 
ampicillin and amoxicillin/clavulanic acid resistant isolates screened negative for all the 
genes tested.  Future work that focuses on further genetic characterization of resistance 
genes expressed, particularly through plasmid profiling, could shed light regarding the 
extent of development and/or of movement of these elements throughout M.haemolytica 
populations within the feedlot environment.   
There is significant concern over the development of antimicrobial resistance as a 
result of antimicrobial use in current cattle production systems.  This concern is 
manifested on both a production level, from producers that face increased production 
costs through increased morbidity and mortality of livestock, and from a public health 
standpoint, where the potential resides for antimicrobial resistant pathogens to infect 
human populations through animal contact or the food chain (Call et al., 2008).  In order 
to address the degree of causality between current practices and the development of 
antimicrobial resistance, surveillance based research is required.  The work conducted 
here is a subsidiary of a larger surveillance program designed to address issues regarding 
antimicrobial use and the development of antimicrobial resistance in enteric, pathogenic 
and zoonotic bacteria in the feedlot sector.  It is hoped that the information presented here 
will be a stepping stone to aid in responsible decision making regarding antimicrobial use 
in the food production industry, the intention to help maximize antimicrobials as a 
resource while minimizing the threat of antimicrobial resistance as a result of their use.   
Because BRD is a continuing problem in the cattle production, insight into the 
major causative agents of the condition will only serve toward the development of better 
management strategies whether that be drug therapy or otherwise.  The works presented 
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here depicts M. haemolytica as a very genetically diverse pathogen with low levels of 
AMR against the types of antimicrobials tested and hints at some puzzles as to the 
dynamics of this species within the feedlot setting.  The information here provides a good 
starting point from which to direct further investigation regarding M. haemolytica as it is 
clear that more work focusing on the epidemiology of this pathogen within the feedlot 
sector is needed.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  98 
REFERENCES 
 
ABP, 2009, Alberta cattle industry statistics. Retrieved October 19, 2009 from 
http://albertabeef.org/consumers/new-page/- 
 
Abdullah, K.M., Lo, R.Y., Mellors, A., 1991, Cloning, nucleotide sequence, and 
expression of the Pasteurella haemolytica A1 glycoprotease gene. J Bacteriol 
173, 5597-5603. 
 
Ackermann, M.R., Brogden, K.A., 2000, Response of the ruminant respiratory tract to 
Mannheimia (Pasteurella) haemolytica. Microbes Infect 2, 1079-1088. 
 
Adams, O.R., Brown, W.W., Chow, T.L., Collier, J.R., Davis, R.W., Griner, L.A., 
Jensen, R., Pierson, R.E., Wayt, L.K., 1959, Comparison of infectious bovine 
rhinotracheitis, shipping fever, and calf diphtheria of cattle. J Am Vet Med Assoc 
134, 85-89. 
 
Adamu, J.Y., 2007, Mannheimia haemolytica: Phylogeny and genetic analysis of its 
major virulence factors. Israel J Vet Med 62, 6-13. 
 
Al-Ghamdi, G.M., Ames, T.R., Baker, J.C., Walker, R., Chase, C.C., Frank, G.H., 
Maheswaran, S.K., 2000, Serotyping of Mannheimia (Pasteurella) haemolytica 
isolates from the upper Midwest United States. J Vet Diagn Invest 12, 576-578. 
 
Alexander, T.W., Cook, S.R., Yanke, L.J., Booker, C.W., Morley, P.S., Read, R.R., Gow, 
S.P., McAllister, T.A., 2008b, A multiplex polymerase chain reaction assay for 
the identification of Mannheimia haemolytica, Mannheimia glucosida and 
Mannheimia ruminalis. Vet Microbiol 130, 165-175. 
 
Angen, O., Ahrens, P., Bisgaard, M., 2002, Phenotypic and genotypic characterization of 
Mannheimia (Pasteurella) haemolytica-like strains isolated from diseased animals 
in Denmark. Vet Microbiol 84, 103-114. 
 
Angen, O., Mutters, R., Caugant, D.A., Olsen, J.E., Bisgaard, M., 1999, Taxonomic 
relationships of the [Pasteurella] haemolytica complex as evaluated by DNA-
DNA hybridizations and 16S rRNA sequencing with proposal of Mannheimia 
haemolytica gen. nov., comb. nov., Mannheimia granulomatis comb. nov., 
Mannheimia glucosida sp. nov., Mannheimia ruminalis sp. nov. and Mannheimia 
varigena sp. nov. Int J Syst Bacteriol 49 Pt 1, 67-86. 
 
Apley, M., 2006, Bovine respiratory disease: pathogenesis, clinical signs, and treatment 
in lightweight calves. Vet Clin North Am Food Anim Pract 22, 399-411. 
 
Babcock, A.H., White, B.J., Dritz, S.S., Thomson, D.U., Renter, D.G., 2008, Feedlot 
health and performance effects associated with the timing of respiratory disease 
treatment. J Anim Sci 87, 314-327 
  99 
 
Bateman, K.G., Martin, S.W., Shewen, P.E., Menzies, P.I., 1990, An evaluation of 
antimicrobial therapy for undifferentiated bovine respiratory disease. Can Vet J 
31, 689-696. 
 
Berge, A.C., Sischo, W.M., Craigmill, A.L., 2006, Antimicrobial susceptibility patterns 
of respiratory tract pathogens from sheep and goats. J Am Vet Med Assoc 229, 
1279-1281. 
 
Berggren, K.A., Baluyut, C.S., Simonson, R.R., Bemrick, W.J., Maheswaran, S.K., 1981, 
Cytotoxic effects of Pasteurella haemolytica on bovine neutrophils. Am J Vet Res 
42, 1383-1388. 
 
Biberstein, E.L., Francis, C.K., 1968, Nucleic acid homologies between the A and T 
types of Pasteurella haemolytica. J Med Microbiol 1, 105-108. 
 
Biberstein, E.L., Gills, M., Knight, H., 1960, Serological types of Pasteurella 
haemolytica. Cornell Vet 50, 283-300. 
 
Bingham, D.P., Moore, R., Richards, A.B., 1990, Comparison of DNA:DNA homology 
and enzymatic activity between Pasteurella haemolytica and related species. Am 
J Vet Res 51, 1161-1166. 
 
Bisgaard, M., 1984, Comparative investigations of Pasteurella haemolytica sensu stricto 
and so-called P. haemolytica isolated from different pathological lesions in pigs. 
Acta Pathol Microbiol Immunol Scand [B] 92, 201-207. 
 
Blackalu, P., Angen, Fegan, N., Blackall, L., Mutters, R., Bisgaard, M., 2001, 
Characterisation of a novel Mannheimia sp from Australian feedlot cattle. Aust 
Vet J 79, 634-639. 
 
Booker, C.W., Abutarbush, S.M., Morley, P.S., Jim, G.K., Pittman, T.J., Schunicht, O.C., 
Perrett, T., Wildman, B.K., Fenton, R.K., Guichon, P.T., Janzen, E.D., 2008, 
Microbiological and histopathological findings in cases of fatal bovine respiratory 
disease of feedlot cattle in western Canada. Can Vet J 49, 473-481. 
 
Booker, C.W., Guichon, P.T., Jim, G.K., Schunicht, O.C., Harland, R.J., Morley, P.S., 
1999, Seroepidemiology of undifferentiated fever in feedlot calves in western 
Canada. Can Vet J 40, 40-48. 
 
Booker, C.W., Jim, G.K., Guichon, P.T., Schunicht, O.C., Thorlakson, B.E., Lockwood, 
P.W., 1997, Evaluation of florfenicol for the treatment of undifferentiated fever in 
feedlot calves in western Canada. Can Vet J 38, 555-560. 
 
Bowland, S.L., Shewen, P.E., 2000, Bovine respiratory disease: commercial vaccines 
currently available in Canada. Can Vet J 41, 33-48. 
  100 
 
Breider, M.A., Kumar, S., Corstvet, R.E., 1990, Bovine pulmonary endothelial cell 
damage mediated by Pasteurella haemolytica pathogenic factors. Infect Immun 
58, 1671-1677. 
 
Brogden, K.A., Adlam, C., Lehmkuhl, H.D., Cutlip, R.C., Knights, J.M., Engen, R.L., 
1989, Effect of Pasteurella haemolytica (A1) capsular polysaccharide on sheep 
lung in vivo and on pulmonary surfactant in vitro. Am J Vet Res 50, 555-559. 
 
Brogden, K.A., Lehmkuhl, H.D., Cutlip, R.C., 1998, Pasteurella haemolytica 
complicated respiratory infections in sheep and goats. Vet Res 29, 233-254. 
 
Brown, G.B., Bolin, S.R., Frank, D.E., Roth, J.A., 1991, Defective function of leukocytes 
from cattle persistently infected with bovine viral diarrhea virus, and the influence 
of recombinant cytokines. Am J Vet Res 52, 381-387. 
 
Brown, T.T., Jr., Ananaba, G., 1988, Effect of respiratory infections caused by bovine 
herpesvirus-1 or parainfluenza-3 virus on bovine alveolar macrophage functions. 
Am J Vet Res 49, 1447-1451. 
 
Burrows, L.L., Olah-Winfield, E., Lo, R.Y., 1993, Molecular analysis of the leukotoxin 
determinants from Pasteurella haemolytica serotypes 1 to 16. Infect Immun 61, 
5001-5007. 
 
Call, D.R., Davis, M.A., Sawant, A.A., 2008, Antimicrobial resistance in beef and dairy 
cattle production. Anim Health Res Rev 9, 159-167. 
 
Caprioli, A., Busani, L., Martel, J.L., Helmuth, R., 2000, Monitoring of antibiotic 
resistance in bacteria of animal origin: epidemiological and microbiological 
methodologies. Int J Antimicrob Agents 14, 295-301. 
 
Carson, C.A., Reid-Smith, R., Irwin, R.J., Martin, W.S., McEwen, S.A., 2008, 
Antimicrobial use on 24 beef farms in Ontario. Can J Vet Res 72, 109-118. 
 
Catry, B., Baele, M., Opsomer, G., de Kruif, A., Decostere, A., Haesebrouck, F., 2004, 
tRNA-intergenic spacer PCR for the identification of Pasteurella and 
Mannheimia spp. Vet Microbiol 98, 251-260. 
 
Catry, B., Dewulf, J., de Kruif, A., Vanrobaeys, M., Haesebrouck, F., Decostere, A., 
2007, Accuracy of susceptibility testing of Pasteurella multocida and 
Mannheimia haemolytica. Microbial Drug Resist 13, 204-211. 
 
Catry, B., Haesebrouck, F., Vliegher, S.D., Feyen, B., Vanrobaeys, M., Opsomer, G., 
Schwarz, S., Kruif, A.D., 2005, Variability in acquired resistance of Pasteurella 
and Mannheimia isolates from the nasopharynx of calves, with particular 
reference to different herd types. Microb Drug Resist 11, 387-394. 
  101 
 
Catry, B., Laevens, H., Devriese, L.A., Opsomer, G., De Kruif, A., 2003, Antimicrobial 
resistance in livestock. J Vet Pharmacol Ther 26, 81-93. 
 
Centers for Disease Control and Prevention. 1996.  Standardized molecular subtyping of 
food borne bacterial pathogens by pulsed-field gel electrophoresis: a manual. 
National Center for Infectious Diseases, Atlanta, GA, USA (updated 2000) 
 
Clinical and Laboratory Standards Institute, 2008. Performance standards for 
antimicrobial susceptibility testing, 18th informational supplement M100-S18, 
Wayne, PA. 
 
Clinical and Laboratory Standards Institute, 2006. Methods for dilution antimicrobial 
susceptibility tests for bacteria that grow aerobically; approved standard M7-A7. 
CLSI, Wayne, PA. 
 
Chae, C.H., Gentry, M.J., Confer, A.W., Anderson, G.A., 1990, Resistance to host 
immune defense mechanisms afforded by capsular material of Pasteurella 
haemolytica, serotype 1. Vet Microbiol 25, 241-251. 
 
Chaslus-Dancla, E., Lesage-Descauses, M.C., Leroy-Setrin, S., Martel, J.L., Lafont, J.P., 
1995, Tetracycline resistance determinants, Tet B and Tet M, detected in 
Pasteurella haemolytica and Pasteurella multocida from bovine herds. J 
Antimicrob Chemother 36, 815-819. 
 
Chen, J., Yu, Z., Michel, F.C., Jr., Wittum, T., Morrison, M., 2007, Development and 
application of real-time PCR assays for quantification of erm genes conferring 
resistance to macrolides-lincosamides-streptogramin B in livestock manure and 
manure management systems. Appl Environ Microbiol 73, 4407-4416. 
 
Chopra, I., Roberts, M., 2001, Tetracycline antibiotics: mode of action, applications, 
molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol 
Rev 65, 232-260 
 
Chou, C.H., Wang, C., 2006, Genetic relatedness between Listeria monocytogenes 
isolates from seafood and humans using PFGE and REP-PCR. Int J Food 
Microbiol 110, 135-148. 
 
Church, T.L., Radostits, O.M., 1981, A retrospective survey of diseases of feedlot cattle 
in Alberta. Can Vet J 22, 27-30. 
 
Clinkenbeard, K.D., Clarke, C.R., Hague, C.M., Clinkenbeard, P., Srikumaran, S., 
Morton, R.J., 1994, Pasteurella haemolytica leukotoxin-induced synthesis of 
eicosanoids by bovine neutrophils in vitro. J Leukoc Biol 56, 644-649. 
 
  102 
Clinkenbeard, K.D., Upton, M.L., 1991, Lysis of bovine platelets by Pasteurella 
haemolytica leukotoxin. Am J Vet Res 52, 453-457. 
 
Confer, A.W., Panciera, R.J., Mosier, D.A., 1988, Bovine pneumonic pasteurellosis: 
immunity to Pasteurella haemolytica. J Am Vet Med Assoc 193, 1308-1316. 
 
Corbeil, L.B., Woodward, W., Ward, A.C., Mickelsen, W.D., Paisley, L., 1985, Bacterial 
interactions in bovine respiratory and reproductive infections. J Clin Microbiol 
21, 803-807. 
 
Corkill, J.E., Graham, R., Hart, C.A., Stubbs, S., 2000, Pulsed-field gel electrophoresis of 
degradation-sensitive DNAs from Clostridium difficile PCR ribotype 1 strains. J 
Clin Microbiol 38, 2791-2792. 
 
D., Spratt, B.G., LiPuma, J.J., 2007, Using BOX-PCR to exclude a clonal outbreak of 
melioidosis. BMC Infect Dis 7, 68. 
 
Cusack, P.M., McMeniman, N., Lean, I.J., 2003, The medicine and epidemiology of 
bovine respiratory disease in feedlots. Aust Vet J 81, 480-487. 
 
Dabo, S.M., Confer, A., Montelongo, M., York, P., Wyckoff, J.H., 3rd, 2008, 
Vaccination with Pasteurella multocida recombinant OmpA induces strong but 
non-protective and deleterious Th2-type immune response in mice. Vaccine 26, 
4345-4351. 
 
Dassanayake, R.P., Shanthalingam, S., Davis, W.C., Srikumaran, S., 2007, Mannheimia 
haemolytica leukotoxin-induced cytolysis of ovine (Ovis aries) leukocytes is 
mediated by CD18, the beta subunit of beta2-integrins. Microb Pathog 42, 167-
173. 
 
Davies, R.L., Arkinsaw, S., Selander, R.K., 1997a, Evolutionary genetics of Pasteurella 
haemolytica isolates recovered from cattle and sheep. Infect Immun 65, 3585-
3593. 
 
Davies, R.L., Arkinsaw, S., Selander, R.K., 1997b, Genetic relationships among 
Pasteurella trehalosi isolates based on multilocus enzyme electrophoresis. 
Microbiology 143 ( Pt 8), 2841-2849. 
 
Davies, R.L., Baillie, S., 2003, Cytotoxic activity of Mannheimia haemolytica strains in 
relation to diversity of the leukotoxin structural gene lktA. Vet Microbiol 92, 263-
279. 
 
Davies, R.L., Campbell, S., Whittam, T.S., 2002, Mosaic structure and molecular 
evolution of the leukotoxin operon (lktCABD) in Mannheimia (Pasteurella) 
haemolytica, Mannheimia glucosida, and Pasteurella trehalosi. J Bacteriol 184, 
266-277. 
  103 
 
Davies, R.L., Donachie, W., 1996, Intra-specific diversity and host specificity within 
Pasteurella haemolytica based on variation of capsular polysaccharide, 
lipopolysaccharide and outer-membrane proteins. Microbiology 142 ( Pt 7), 1895-
1907. 
 
Davies, R.L., Paster, B.J., Dewhirst, F.E., 1996, Phylogenetic relationships and diversity 
within the Pasteurella haemolytica complex based on 16S rRNA sequence 
comparison and outer membrane protein and lipopolysaccharide analysis. Int J 
Syst Bacteriol 46, 736-744. 
 
Davies, R.L., Whittam, T.S., Selander, R.K., 2001, Sequence diversity and molecular 
evolution of the leukotoxin (lktA) gene in bovine and ovine strains of 
Mannheimia (Pasteurella) haemolytica. J Bacteriol 183, 1394-1404. 
 
De Ley, J., Mannheim, W., Mutters, R., Piechulla, K., Tytgat, R., Segers, P., Bisgaard, 
M., Frederiksen, W., Hinz, K.H., Vanhoucke, M., 1990, Inter- and intrafamilial 
similarities of rRNA cistrons of the Pasteurellaceae. Int J Syst Bacteriol 40, 126-
137. 
 
De Vuyst, L., Camu, N., De Winter, T., Vandemeulebroecke, K., Van de Perre, V., 
Vancanneyt, M., De Vos, P., Cleenwerck, I., 2008, Validation of the (GTG)5-rep-
PCR fingerprinting technique for rapid classification and identification of acetic 
acid bacteria, with a focus on isolates from Ghanaian fermented cocoa beans. Int J 
Food Microbiol 125, 79-90. 
 
Dewhirst, F.E., Paster, B.J., Olsen, I., Fraser, G.J., 1992, Phylogeny of 54 representative 
strains of species in the family Pasteurellaceae as determined by comparison of 
16S rRNA sequences. J Bacteriol 174, 2002-2013. 
 
Dewhirst, F.E., Paster, B.J., Olsen, I., Fraser, G.J., 1993, Phylogeny of the 
Pasteurellaceae as determined by comparison of 16S ribosomal ribonucleic acid 
sequences. Zentralbl Bakteriol 279, 35-44. 
 
Donachie, W., Fraser, J., Quirie, M., Gilmour, N.J., 1984, Studies on strains of 
Pasteurella haemolytica not typeable by the indirect haemagglutination test. Res 
Vet Sci 37, 188-193. 
 
Duff, G.C., Galyean, M.L., 2007, Board-invited review: recent advances in management 
of highly stressed, newly received feedlot cattle. J Anim Sci 85, 823-840. 
 
Edwards, A.J., 1996, Respiratory diseases of feedlot cattle in the central USA. Bovine 
Pract. 30. 
 
Encinias, A.M., Walker, D.A., Murdock, C.W., Reeves, L.A., Malcolm-Callis, K.J., Soto-
Navarro, S., 2006. Effects of prophylactic administration of ceftiofur crystalline 
  104 
free acid on health and performance of newly received beef calves. In:  
Proceedings- American Society of Animal Science, Western Section Utah State 
University in Logan, Utah. 
 
Escande, F., Gerbaud, G., Martel, J.L., Courvalin, P., 1991, Resistance to trimethoprim 
and 2,4-diamino-6,7-diisopropyl-pteridine (0/129) in Pasteurella haemolytica. 
Vet Microbiol 26, 107-114. 
 
Ewers, C., Lubke-Becker, A., Wieler, L.H., 2004, Pasteurella: insights into the virulence 
determinants of a heterogenous bacterial type. Berl Munch Tierarztl Wochenschr 
117, 367-386. 
 
Filion, L.G., Willson, P.J., Bielefeldt-Ohmann, H., Babiuk, L.A., Thomson, R.G., 1984, 
The possible role of stress in the induction of pneumonic pasteurellosis. Can J 
Comp Med 48, 268-274. 
 
Foxman, B., Zhang, L., Koopman, J.S., Manning, S.D., Marrs, C.F., 2005, Choosing an 
appropriate bacterial typing technique for epidemiologic studies. Epidemiol 
Perspect Innov 2, 10. 
 
Frank, G.H., 1980, Serological groups among untypeable bovine isolates of Pasteurella 
haemolytica. J Clin Microbiol 12, 579-582. 
 
Frank, G.H., Briggs, R.E., Loan, R.W., Purdy, C.W., Zehr, E.S., 1996, Respiratory tract 
disease and mucosal colonization by Pasteurella haemolytica in transported 
cattle. Am J Vet Res 57, 1317-1320. 
 
Frank, G.H., Wessman, G.E., 1978, Rapid plate agglutination procedure for serotyping 
Pasteurella haemolytica. J Clin Microbiol 7, 142-145. 
 
Friend, S.C., Thomson, R.G., Wilkie, B.N., 1977, Pulmonary lesions induced by 
Pasteurella haemolytica in cattle. Can J Comp Med 41, 219-223. 
 
Gagea, M.I., Bateman, K.G., van Dreumel, T., McEwen, B.J., Carman, S., Archambault, 
M., Shanahan, R.A., Caswell, J.L., 2006, Diseases and pathogens associated with 
mortality in Ontario beef feedlots. J Vet Diagn Invest 18, 18-28. 
 
Gardner, B.A., Dolezal, H.G., Bryant, L.K., Owens, F.N., Smith, R.A., 1999, Health of 
finishing steers: effects on performance, carcass traits, and meat tenderness. J 
Anim Sci 77, 3168-3175. 
 
Gevaert, D., 2006, The importance of Mycoplasma bovis in bovine respiratory disease. 
Tijdschr Diergeneeskd 131, 124-126. 
 
Gevers, D., Huys, G., Swings, J., 2001, Applicability of rep-PCR fingerprinting for 
identification of Lactobacillus species. FEMS Microbiol Lett 205, 31-36. 
  105 
 
Gioia, J., Qin, X., Jiang, H., Clinkenbeard, K., Lo, R., Liu, Y., Fox, G.E., Yerrapragada, 
S., McLeod, M.P., McNeill, T.Z., Hemphill, L., Sodergren, E., Wang, Q., Muzny, 
D.M., Homsi, F.J., Weinstock, G.M., Highlander, S.K., 2006, The genome 
sequence of Mannheimia haemolytica A1: insights into virulence, natural 
competence, and Pasteurellaceae phylogeny. J Bacteriol 188, 7257-7266. 
 
Graham, W.R., 1953, The pathology of shipping fever in feedlot cattle. J Am Vet Med 
Assoc 123, 198-203. 
 
Griffin, D., 1997, Economic impact associated with respiratory disease in beef cattle. Vet 
Clin North Am Food Anim Pract 13, 367-377. 
 
Guenther, S., Schierack, P., Grobbel, M., Lubke-Becker, A., Wieler, L.H., Ewers, C., 
2008, Real-time PCR assay for the detection of species of the genus Mannheimia. 
J Microbiol Methods 75, 75-80. 
 
Gunawardana, G.A., Townsend, K.M., Frost, A.J., 2000, Molecular characterization of 
avian Pasteurella multocida isolates from Australia and Vietnam by REP-PCR 
and PFGE. Vet Microbiol 72, 97-109. 
 
Hansen, L.M., Blanchard, P.C., Hirsh, D.C., 1996, Distribution of tet(H) among 
Pasteurella isolates from the United States and Canada. Antimicrob Agents 
Chemother 40, 1558-1560. 
 
Hansen, L.M., McMurry, L.M., Levy, S.B., Hirsh, D.C., 1993, A new tetracycline 
resistance determinant, Tet H, from Pasteurella multocida specifying active efflux 
of tetracycline. Antimicrob Agents Chemother 37, 2699-2705. 
 
Harland, R.J., Jim, G.K., Guichon, P.T., Townsend, H.G., Janzen, E.D., 1991, Efficacy of 
parenteral antibiotics for disease prophylaxis in feedlot calves. Can Vet J 32, 163-
168. 
 
Healy, M., Huong, J., Bittner, T., Lising, M., Frye, S., Raza, S., Schrock, R., Manry, J., 
Renwick, A., Nieto, R., Woods, C., Versalovic, J., Lupski, J.R., 2005, Microbial 
DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol 43, 
199-207. 
 
Hendriksen, R.S., Mevius, D.J., Schroeter, A., Teale, C., Meunier, D., Butaye, P., Franco, 
A., Utinane, A., Amado, A., Moreno, M., Greko, C., Stark, K., Berghold, C., 
Myllyniemi, A.L., Wasyl, D., Sunde, M., Aarestrup, F.M., 2008, Prevalence of 
antimicrobial resistance among bacterial pathogens isolated from cattle in 
different European countries: 2002-2004. Acta Vet Scand 50, 28. 
 
Henricks, P.A., Binkhorst, G.J., Drijver, A.A., Nijkamp, F.P., 1992, Pasteurella 
haemolytica leukotoxin enhances production of leukotriene B4 and 5-
  106 
hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes. Infect 
Immun 60, 3238-3243. 
 
Highlander, S.K., 2001, Molecular genetic analysis of virulence in Mannheimia 
(pasteurella) haemolytica. Front Biosci 6, D1128-1150. 
 
Highlander, S.K., Fedorova, N.D., Dusek, D.M., Panciera, R., Alvarez, L.E., Rinehart, 
C., 2000, Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin 
causes partial attenuation of virulence in a calf challenge model. Infect Immun 68, 
3916-3922. 
 
Hoar, B.R., Jelinski, M.D., Ribble, C.S., Janzen, E.D., Johnson, J.C., 1998, A comparison 
of the clinical field efficacy and safety of florfenicol and tilmicosin for the 
treatment of undifferentiated bovine respiratory disease of cattle in western 
Canada. Can Vet J 39, 161-166. 
 
Hodgins, D.C., Conlon, J.A., Shewen, P.E., 2002, Respiratory viruses and bacteria in 
cattle, In:  Brogden, K.A., Guthmiller, J.M. (Eds.) Polymicrobial diseases. ASM 
Press, Washinton DC, pp. 213-230. 
 
Hunter, P.R., Gaston, M.A., 1988, Numerical index of the discriminatory ability of typing 
systems: an application of Simpson's index of diversity. J Clin Microbiol 26, 
2465-2466. 
 
Hunter, S.B., Vauterin, P., Lambert-Fair, M.A., Van Duyne, M.S., Kubota, K., Graves, 
L., Wrigley, D., Barrett, T., Ribot, E., 2005, Establishment of a universal size 
standard strain for use with the PulseNet standardized pulsed-field gel 
electrophoresis protocols: converting the national databases to the new size 
standard. J Clin Microbiol 43, 1045-1050. 
 
Jaworski, M.D., Hunter, D.L., Ward, A.C., 1998, Biovariants of isolates of Pasteurella 
from domestic and wild ruminants. J Vet Diagn Invest 10, 49-55. 
 
Jericho, K.W., 1979, Update on pasteurellosis in young cattle. Can Vet J 20, 333-335. 
 
Jeyaseelan, S., Sreevatsan, S., Maheswaran, S.K., 2002, Role of Mannheimia 
haemolytica leukotoxin in the pathogenesis of bovine pneumonic pasteurellosis. 
Anim Health Res Rev 3, 69-82. 
 
Jim, G.K., Booker, C.W., Guichon, P.T., Schunicht, O.C., Wildman, B.K., Johnson, J.C., 
Lockwood, P.W., 1999, A comparison of florfenicol and tilmicosin for the 
treatment of undifferentiated fever in feedlot calves in western Canada. Can Vet J 
40, 179-184. 
 
  107 
Johnson, J.R., O'Bryan, T.T., 2000, Improved repetitive-element PCR fingerprinting for 
resolving pathogenic and nonpathogenic phylogenetic groups within Escherichia 
coli. Clin Diagn Lab Immunol 7, 265-273. 
 
Jones, F., 1921, A study of Bacillus bovisepticus. . J Exp Med 34, 561-577. 
 
Katsuda, K., Kamiyama, M., Kohmoto, M., Kawashima, K., Tsunemitsu, H., Eguchi, M., 
2007, Serotyping of Mannheimia haemolytica isolates from bovine pneumonia: 
1987-2006. Vet J. 
 
Katsuda, K., Kohmoto, M., Kawashima, K., Tsunemitsu, H., Tsuboi, T., Eguchi, M., 
2003, Molecular typing of Mannheimia (Pasteurella) haemolytica serotype A1 
isolates from cattle in Japan. Epidemiol Infect 131, 939-946. 
 
Kehrenberg, C., Catry, B., Haesebrouck, F., de Kruif, A., Schwarz, S., 2005a, Novel 
spectinomycin/streptomycin resistance gene, aadA14, from Pasteurella 
multocida. Antimicrob Agents Chemother 49, 3046-3049. 
 
Kehrenberg, C., Catry, B., Haesebrouck, F., de Kruif, A., Schwarz, S., 2005b, tet(L)-
mediated tetracycline resistance in bovine Mannheimia and Pasteurella isolates. J 
Antimicrob Chemother 56, 403-406. 
 
Kehrenberg, C., Salmon, S.A., Watts, J.L., Schwarz, S., 2001a, Tetracycline resistance 
genes in isolates of Pasteurella multocida, Mannheimia haemolytica, Mannheimia 
glucosida and Mannheimia varigena from bovine and swine respiratory disease: 
intergeneric spread of the tet(H) plasmid pMHT1. J Antimicrob Chemother 48, 
631-640. 
 
Kehrenberg, C., Schulze-Tanzil, G., Martel, J.L., Chaslus-Dancla, E., Schwarz, S., 
2001b, Antimicrobial resistance in Pasteurella and Mannheimia: epidemiology 
and genetic basis. Vet Res 32, 323-339. 
 
Kehrenberg, C., Schwarz, S., 2001, Occurrence and linkage of genes coding for 
resistance to sulfonamides, streptomycin and chloramphenicol in bacteria of the 
genera Pasteurella and Mannheimia. FEMS Microbiol Lett 205, 283-290. 
 
Kehrenberg, C., Schwarz, S., 2005a, dfrA20, A novel trimethoprim resistance gene from 
Pasteurella multocida. Antimicrob Agents Chemother 49, 414-417. 
 
Kehrenberg, C., Schwarz, S., 2005b, Plasmid-borne florfenicol resistance in Pasteurella 
multocida. J Antimicrob Chemother 55, 773-775. 
 
Kehrenberg, C., Walker, R., Wu, C., Schwarz, S., 2006, Antimicrobial resistance in 
members of the family Pasteurellaceae, In:  Aarestrup, F.M. (Ed.) Antimicrobial 
resistance in bacteria of animal origin. ASM Press, Washinton DC, pp. 167-186. 
 
  108 
Keiss, R.E., Will, D.H., Collier, J.R., 1964, Skin toxicity and hemodynamic properties of 
endotoxin derived from Pasteurella haemolytica. Am J Vet Res 25, 935-942. 
 
Kelley, S.T., Cassirer, E.F., Weiser, G.C., Safaee, S., 2007, Phylogenetic diversity of 
Pasteurellaceae and horizontal gene transfer of leukotoxin in wild and domestic 
sheep. Infect Genet Evol 7, 13-23. 
 
Kim, E., Aoki, T., 1996, Sequence analysis of the florfenicol resistance gene encoded in 
the transferable R-plasmid of a fish pathogen, Pasteurella piscicida. Microbiol 
Immunol 40, 665-669. 
 
Kitt, T., 1885, Uber eine experimentelle, der Rinderseuche ahnliche Infektionskranheit. 
Sitzunbsber Ges Morphol Physiol Muenchen, 140-168. 
 
Kodjo, A., Villard, L., Bizet, C., Martel, J.L., Sanchis, R., Borges, E., Gauthier, D., 
Maurin, F., Richard, Y., 1999, Pulsed-field gel electrophoresis is more efficient 
than ribotyping and random amplified polymorphic DNA analysis in 
discrimination of Pasteurella haemolytica strains. J Clin Microbiol 37, 380-385. 
 
Lacroix, R.P., Duncan, J.R., Jenkins, R.P., Leitch, R.A., Perry, J.A., Richards, J.C., 1993, 
Structural and serological specificities of Pasteurella haemolytica 
lipopolysaccharides. Infect Immun 61, 170-181. 
 
Lalman, D., Smith, R. 2002. Effects of Preconditioning on Health, Performance and 
Prices of Weaned Calves. In Oklahoma Cooperative Extension Service 
(Oklahoma State University). 
 
Larsen, J., Pedersen, A.G., Davies, R.L., Kuhnert, P., Frey, J., Christensen, H., Bisgaard, 
M., Olsen, J.E., 2009, Evolution of the leukotoxin promoter in genus 
Mannheimia. BMC Evol Biol 9, 121. 
 
Larson, R.L., 2005, Effect of cattle disease on carcass trait. J. Anim. Sci. 83, 37-47. 
 
Larson, R.L., Tyler, J.W., 2005, Reducing calf losses in beef herds. Vet Clin North Am 
Food Anim Pract 21, 569-584. 
 
Lee, C.W., Shewen, P.E., 1996, Evidence of bovine immunoglobulin G1 (IgG1) protease 
activity in partially purified culture supernate of Pasteurella haemolytica A1. Can 
J Vet Res 60, 127-132. 
 
Li, J., Clinkenbeard, K.D., 1999, Lipopolysaccharide complexes with Pasteurella 
haemolytica leukotoxin. Infect Immun 67, 2920-2927. 
 
Lillie, L.E., 1974, The bovine respiratory disease complex. Can Vet J 15, 233-242. 
 
  109 
Lo, R.Y., 2001, Genetic analysis of virulence factors of Mannheimia (Pasteurella) 
haemolytica A1. Veterinary microbiology 83, 23-35. 
 
Loneragan, G.H., Thomson, D.U., Montgomery, D.L., Mason, G.L., Larson, R.L., 2005, 
Prevalence, outcome, and health consequences associated with persistent infection 
with bovine viral diarrhea virus in feedlot cattle. J Am Vet Med Assoc 226, 595-
601. 
 
Lopez, A., Thomson, R.G., Savan, M., 1976, The pulmonary clearance of Pasteurella 
haemolytica in calves infected with bovine parainfluenza-3 virus. Can J Comp 
Med 40, 385-391. 
 
Maheswaran, S.K., Berggren, K.A., Simonson, R.R., Ward, G.E., Muscoplat, C.C., 1980, 
Kinetics of interaction and fate of Pasteurella haemolytica in bovine alveolar 
macrophages. Infect Immun 30, 254-262. 
 
Maheswaran, S.K., Weiss, D.J., Kannan, M.S., Townsend, E.L., Reddy, K.R., Whiteley, 
L.O., Srikumaran, S., 1992, Effects of Pasteurella haemolytica A1 leukotoxin on 
bovine neutrophils: degranulation and generation of oxygen-derived free radicals. 
Vet Immunol Immunopathol 33, 51-68. 
 
Malott, R.J., Lo, R.Y., 2002, Studies on the production of quorum-sensing signal 
molecules in Mannheimia haemolytica A1 and other Pasteurellaceae species. 
FEMS Microbiol Lett 206, 25-30. 
 
Mannheim, W., 1983, Taxonomy of the family Pasteurellaceae Pohl 1981 as revealed by 
DNA:DNA hybridization. INSERM 114, 211-226. 
 
Martin, S.W., Meek, A.H., Davis, D.G., Johnson, J.A., Curtis, R.A., 1981, Factors 
associated with morbidity and mortality in feedlot calves: the Bruce County beef 
project, year two. Can J Comp Med 45, 103-112. 
 
Martin, S.W., Meek, A.H., Davis, D.G., Thomson, R.G., Johnson, J.A., Lopez, A., 
Stephens, L., Curtis, R.A., Prescott, J.F., Rosendal, S., Savan, M., Zubaidy, A.J., 
Bolton, M.R., 1980, Factors associated with mortality in feedlot cattle: the Bruce 
County Beef Cattle Project. Can J Comp Med 44, 1-10. 
 
Masco, L., Huys, G., Gevers, D., Verbrugghen, L., Swings, J., 2003, Identification of 
Bifidobacterium species using rep-PCR fingerprinting. Syst Appl Microbiol 26, 
557-563. 
 
McVey, D.S., Loan, R.W., Purdy, C.W., Shuman, W.J., 1990, Specificity of bovine 
serum antibody to capsular carbohydrate antigens from Pasteurella haemolytica. J 
Clin Microbiol 28, 1151-1158. 
 
  110 
Mohamed, R.A., Abdelsalam, E.B., 2008, A review on pneumonic pasteurellosis 
(respiratory mannheimiosis) with emphasis on pathogenesis, virulence 
mechanisms and predisposing factors Bulgarian J Vet Med 11, 139-160. 
 
Mohapatra, B.R., Broersma, K., Mazumder, A., 2008, Differentiation of fecal 
Escherichia coli from poultry and free-living birds by (GTG)5-PCR genomic 
fingerprinting. Int J Med Microbiol 298, 245-252. 
 
Mohapatra, B.R., Mazumder, A., 2008, Comparative efficacy of five different rep-PCR 
methods to discriminate Escherichia coli populations in aquatic environments. 
Water Sci Technol 58, 537-547. 
 
Morck, D.W., Olson, M.E., Acres, S.D., Daoust, P.Y., Costerton, J.W., 1989, Presence of 
bacterial glycocalyx and fimbriae on Pasteurella haemolytica in feedlot cattle 
with pneumonic pasteurellosis. Can J Vet Res 53, 167-171. 
 
Morck, D.W., Raybould, T.J., Acres, S.D., Babiuk, L.A., Nelligan, J., Costerton, J.W., 
1987, Electron microscopic description of glycocalyx and fimbriae on the surface 
of Pasteurella haemolytica-A1. Can J Vet Res 51, 83-88. 
 
Mraz, O., 1969, Comparative study of species Actinobacillus lignieresii and Pasteurella 
haemolytica. I. Actinobacillus lignieresii BRUMPT, 1910; emend. Zentralbl 
Bakteriol 209, 212-232. 
 
Mutters, R., Bisgaard, M., Pohl, S., 1986, Taxonomic relationship of selected biogroups 
of Pasteurella haemolytica as revealed by DNA:DNA hybridizations. Acta Pathol 
Microbiol Immunol Scand [B] 94, 195-202. 
 
Newson, I.E., and Cross, F., 1932, Some bipolar organisms found in pneumonia in sheep. 
J Am Vet Med Assoc 80, 711-719. 
 
Nyarko, K.A., Coomber, B.L., Mellors, A., Gentry, P.A., 1998, Bovine platelet adhesion 
is enhanced by leukotoxin and sialoglycoprotease isolated from Pasteurella 
haemolytica A1 cultures. Vet Microbiol 61, 81-91. 
 
Pandher, K., Confer, A.W., Murphy, G.L., 1998, Genetic and immunologic analyses of 
PlpE, a lipoprotein important in complement-mediated killing of Pasteurella 
haemolytica serotype 1. Infect Immun 66, 5613-5619. 
 
Post, K.W., Cole, N.A., Raleigh, R.H., 1991, In vitro antimicrobial susceptibility of 
Pasteurella haemolytica and Pasteurella multocida recovered from cattle with 
bovine respiratory disease complex. J Vet Diagn Invest 3, 124-126. 
 
Pritchard, R.H., Mendez, J.K., 1990, Effects of preconditioning on pre- and post-
shipment performance of feeder calves. J Anim Sci 68, 28-34. 
 
  111 
Purdy, C.W., Raleigh, R.H., Collins, J.K., Watts, J.L., Straus, D.C., 1997, Serotyping and 
enzyme characterization of Pasteurella haemolytica and Pasteurella multocida 
isolates recovered from pneumonic lungs of stressed feeder calves. Curr 
Microbiol 34, 244-249. 
 
Rehmtulla, A.J., Thomson, R.G., 1981, A review of the lesions in shipping fever of cattle. 
Can Vet J 22, 1-8. 
 
Ribble, C.S., Meek, A.H., Janzen, E.D., Guichon, P.T., Jim, G.K., 1995a, Effect of time 
of year, weather, and the pattern of auction market sales on fatal fibrinous 
pneumonia (shipping fever) in calves in a large feedlot in Alberta (1985-1988). 
Can J Vet Res 59, 167-172. 
 
Ribble, C.S., Meek, A.H., Jim, G.K., Guichon, P.T., 1995b, The pattern of fatal fibrinous 
pneumonia (shipping fever) affecting calves in a large feedlot in Alberta (1985-
1988). Can Vet J 36, 753-757. 
 
Ribble, C.S., Meek, A.H., Shewen, P.E., Guichon, P.T., Kee G.K., 1995c, Effect of 
pretransit mixing on fatal fibrinous pneumonia in calves.  J Am Vet Med Assoc 5, 
616-619. 
 
Rice, J.A., Carrasco-Medina, L., Hodgins, D.C., Shewen, P.E., 2007, Mannheimia 
haemolytica and bovine respiratory disease. Anim Health Res Rev 8, 117-128. 
 
Rossi, C.R., Kiesel, G.K., 1977, Susceptibility of bovine macrophage and tracheal-ring 
cultures to bovine viruses. Am J Vet Res 38, 1705-1708. 
 
Rowe, H.A., Poxton, I.R., Donachie, W., 2001, Survival of Mannheimia (Pasteurella) 
haemolytica in tracheobronchial washings of sheep and cattle. Vet Microbiol 81, 
305-314. 
 
Ryff, J.F., Glenn, M.W., 1957, Possible evidence of a viral agent in shipping fever 
complex of cattle. J Am Vet Med Assoc 131, 469-470. 
 
Saadati, M., Gibbs, H.A., Parton, R., Coote, J.G., 1997, Characterization of the 
leukotoxin produced by different strains of Pasteurella haemolytica. J Med 
Microbiol 46, 276-284. 
 
Sanderson, M.W., Dargatz, D.A., Wagner, B.A., 2008, Risk factors for initial respiratory 
disease in United States' feedlots based on producer-collected daily morbidity 
counts. Can Vet J 49, 373-378. 
 
Schunicht, O.C., Booker, C.W., Guichon, P.T., Jim, G.K., Wildman, B.K., Hill, B.W., 
Ward, T.I., Bauck, S.W., 2002, An evaluation of the relative efficacy of a new 
formulation of oxytetracycline for the treatment of undifferentiated fever in 
feedlot calves in western Canada. Can Vet J 43, 940-945. 
  112 
 
Schunicht, O.C., Booker, C.W., Guichon, P.T., Jim, G.K., Wildman, B.K., Pittman, T.J., 
Perrett, T., 2007, An evaluation of the relative efficacy of tulathromycin for the 
treatment of undifferentiated fever in feedlot calves in Nebraska. Can Vet J 48, 
600-606. 
 
Schwarz, S., Kehrenberg, C., Salmon, S.A., Watts, J.L., 2004, In vitro activities of 
spectinomycin and comparator agents against Pasteurella multocida and 
Mannheimia haemolytica from respiratory tract infections of cattle. J Antimicrob 
Chemother 53, 379-382. 
 
Sharma, S.A., Olchowy, T.W., Breider, M.A., 1992, Alveolar macrophage and neutrophil 
interactions in Pasteurella haemolytica-induced endothelial cell injury. J Infect 
Dis 165, 651-657. 
 
Shewen, P.E., Wilkie, B.N., 1982, Cytotoxin of Pasteurella haemolytica acting on bovine 
leukocytes. Infect Immun 35, 91-94. 
 
Silbert, S., Boyken, L., Hollis, R.J., Pfaller, M.A., 2003, Improving typeability of 
multiple bacterial species using pulsed-field gel electrophoresis and thiourea. 
Diagn Microbiol Infect Dis 47, 619-621. 
 
Smith, R.A., 1998, Impact of disease on feedlot performance: a review. J Anim Sci 76, 
272-274. 
 
Sneath, P.H., Stevens, M., 1985, A numerical taxonomic study of Actinobacillus, 
Pasteurella and Yersinia. J Gen Microbiol 131, 2711-2738. 
 
Sneath, P.H., Stevens, M., 1990, Actinobacillus rossii sp. nov., Actinobacillus seminis sp. 
nov., nom. rev., Pasteurella bettii sp. nov., Pasteurella lymphangitidis sp. nov., 
Pasteurella mairi sp. nov., and Pasteurella trehalosi sp. nov. Int J Syst Bacteriol 
40, 148-153. 
 
Snowder, G.D., Van Vleck, L.D., Cundiff, L.V., Bennett, G.L., 2006, Bovine respiratory 
disease in feedlot cattle: environmental, genetic, and economic factors. J Anim 
Sci 84, 1999-2008. 
 
Snowder, G.D., Van Vleck, L.D., Cundiff, L.V., Bennett, G.L., Koohmaraie, M., 
Dikeman, M.E., 2007, Bovine respiratory disease in feedlot cattle: phenotypic, 
environmental, and genetic correlations with growth, carcass, and longissimus 
muscle palatability traits. J Anim Sci 85, 1885-1892. 
 
Straus, D.C., Purdy, C.W., Loan, R.W., Briggs, R.F., Frank, G.H., 1998, In vivo 
production of neuraminidase by Pasteurella haemolytica in market stressed cattle 
after natural infection. Curr Microbiol 37, 240-244. 
 
  113 
Sutherland, D.R., Abdullah, K.M., Cyopick, P., Mellors, A., 1992, Cleavage of the cell-
surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel 
glycoprotease from Pasteurella haemolytica. J Immunol 148, 1458-1464. 
 
Tefera, G., and  Smola, J., 2001, Pasteurella haemolytica complex of Pasteurella sensu 
stricto as new genus Mannheimia: changes in taxonomy. Vet Med. 46, 119-124. 
 
Tenover, F.C., Arbeit, R.D., Goering, R.V., 1997, How to select and interpret molecular 
strain typing methods for epidemiological studies of bacterial infections: a review 
for healthcare epidemiologists. Molecular Typing Working Group of the Society 
for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 18, 426-
439. 
 
Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, 
D.H., Swaminathan, B., 1995, Interpreting chromosomal DNA restriction patterns 
produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J 
Clin Microbiol 33, 2233-2239. 
 
Thomson, D.U., White, B.J., 2006, Backgrounding beef cattle. Vet Clin North Am Food 
Anim Pract 22, 373-398. 
 
Thumbikat, P., Dileepan, T., Kannan, M.S., Maheswaran, S.K., 2005, Characterization of 
Mannheimia (Pasteurella) haemolytica leukotoxin interaction with bovine 
alveolar macrophage beta2 integrins. Vet Res 36, 771-786. 
 
Vassort-Bruneau, C., Lesage-Descauses, M.C., Martel, J.L., Lafont, J.P., Chaslus-Dancla, 
E., 1996, CAT III chloramphenicol resistance in Pasteurella haemolytica and 
Pasteurella multocida isolated from calves. J Antimicrob Chemother 38, 205-213. 
 
Villard, L., Gauthier, D., Lacheretz, A., Abadie, G., Game, Y., Maurin, F., Richard, Y., 
Borges, E., Kodjo, A., 2006, Serological and molecular comparison of 
Mannheimia haemolytica and Pasteurella trehalosi strains isolated from wild and 
domestic ruminants in the French Alps. Vet J 171, 545-550. 
 
Villard, L., Gauthier, D., Maurin, F., Borges, E., Richard, Y., Abadie, G., Kodjo, A., 
2008, Serotypes A1 and A2 of Mannheimia haemolytica are susceptible to 
genotypic, capsular and phenotypic variations in contrast to T3 and T4 serotypes 
of Bibersteinia (Pasteurella) trehalosi. FEMS Microbiol Lett 280, 42-49. 
 
Vogel, G.L., Parrott, J.C., 1994, Mortality survey in feedyards: The incidence of death 
from digestive, respiratory and other causes in feedyards of the Great Plains. 
Compend. Contin. Educ. Pract. Vet. 16, 227-234. 
 
Waggoner, J.W., Mathis, C.P., Löest, C.A., Sawyer, J.E., McCollum, F.T., 2005. Impact 
of preconditioning duration on feedlot performance, carcass characteristics and 
profitability of New Mexico ranch to rails steers. In:  Proceedings-  American 
  114 
Society of Animal Science, Western Section, New Mexico State University,  Las 
Cruces, NM. 
 
Wang, Z., Clarke, C., Clinkenbeard, K., 1998, Pasteurella haemolytica leukotoxin-
induced increase in phospholipase A2 activity in bovine neutrophils. Infect 
Immun 66, 1885-1890. 
 
Watts, J.L., Yancey, R.J., Jr., Salmon, S.A., Case, C.A., 1994, A 4-year survey of 
antimicrobial susceptibility trends for isolates from cattle with bovine respiratory 
disease in North America. J Clin Microbiol 32, 725-731. 
 
Weigel, R.M., Qiao, B., Teferedegne, B., Suh, D.K., Barber, D.A., Isaacson, R.E., White, 
B.A., 2004, Comparison of pulsed field gel electrophoresis and repetitive 
sequence polymerase chain reaction as genotyping methods for detection of 
genetic diversity and inferring transmission of Salmonella. Vet Microbiol 100, 
205-217. 
 
Weiser, G.C., Miller, D.S., Drew, M.L., Rhyan, J.C., Ward, A.C., 2009, Variation in 
Pasteurella (Bibersteinia) and Mannheimia spp. following transport and antibiotic 
treatment in free-ranging and captive Rocky Mountain bighorn sheep (Ovis 
canadensis canadensis). J Zoo Wildl Med 40, 117-125. 
 
Welsh, R.D., Dye, L.B., Payton, M.E., Confer, A.W., 2004, Isolation and antimicrobial 
susceptibilities of bacterial pathogens from bovine pneumonia: 1994--2002. J Vet 
Diagn Invest 16, 426-431. 
 
Whiteley, L.O., Maheswaran, S.K., Weiss, D.J., Ames, T.R., 1990, Immunohistochemical 
localization of Pasteurella haemolytica A1-derived endotoxin, leukotoxin, and 
capsular polysaccharide in experimental bovine Pasteurella pneumonia. Vet 
Pathol 27, 150-161. 
 
Whiteley, L.O., Maheswaran, S.K., Weiss, D.J., Ames, T.R., Kannan, M.S., 1992, 
Pasteurella haemolytica A1 and bovine respiratory disease: pathogenesis. J Vet 
Intern Med 6, 11-22. 
 
Wildman, B.K., Perrett, T., Abutarbush, S.M., Guichon, P.T., Pittman, T.J., Booker, 
C.W., Schunicht, O.C., Fenton, R.K., Jim, G.K., 2008, A comparison of 2 
vaccination programs in feedlot calves at ultra-high risk of developing 
undifferentiated fever/bovine respiratory disease. Can Vet J 49, 463-472. 
 
Wittum, T.E., Woollen, N.E., Perino, L.J., Littledike, E.T., 1996, Relationships among 
treatment for respiratory tract disease, pulmonary lesions evident at slaughter, and 
rate of weight gain in feedlot cattle. J Am Vet Med Assoc 209, 814-818. 
 
Woldehiwet, Z., Sharma, R., 1992, Evidence of immunosuppression by bovine 
respiratory syncytial virus. Scand J Immunol Suppl 11, 75-80. 
  115 
 
Wood, A.R., Lainson, F.A., Wright, F., Baird, G.D., Donachie, W., 1995, A native 
plasmid of Pasteurella haemolytica serotype A1: DNA sequence analysis and 
investigation of its potential as a vector. Res Vet Sci 58, 163-168. 
 
Woolums, A.R., Loneragan, G.H., Hawkins, L.L., 2005, Baseline management practices 
and animal health data reported by US feedyards responding to a survey regarding 
acute interstitial pneumonia. Bovine Pract. 39, 116-124. 
 
Yates, W.D., 1982, A review of infectious bovine rhinotracheitis, shipping fever 
pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J 
Comp Med 46, 225-263. 
 
Yokoyama, E., Maruyama, S., Kabeya, H., Hara, S., Sata, S., Kuroki, T., Yamamoto, T., 
2007, Prevalence and genetic properties of Salmonella enterica serovar 
typhimurium definitive phage type 104 isolated from Rattus norvegicus and 
Rattus rattus house rats in Yokohama City, Japan. Appl Environ Microbiol 73, 
2624-2630. 
 
Yoo, H.S., Rajagopal, B.S., Maheswaran, S.K., Ames, T.R., 1995, Purified Pasteurella 
haemolytica leukotoxin induces expression of inflammatory cytokines from 
bovine alveolar macrophages. Microb Pathog 18, 237-252. 
 
Yoo, H.S., Rutherford, M.S., Maheswaran, S.K., Srinand, S., Ames, T.R., 1996, 
Induction of nitric oxide production by bovine alveolar macrophages in response 
to Pasteurella haemolytica A1. Microb Pathog 20, 361-375. 
 
Younan, M., Fodar, L., 1995, Characterisation of a new Pasteurella haemolytica serotype 
(A17). Res Vet Sci 58, 98. 
 
Zecchinon, L., Fett, T., Desmecht, D., 2005, How Mannheimia haemolytica defeats host 
defence through a kiss of death mechanism. Vet Res 36, 133-156. 
 
Zhang, Y., Yakrus, M.A., Graviss, E.A., Williams-Bouyer, N., Turenne, C., Kabani, A., 
Wallace, R.J., Jr., 2004, Pulsed-field gel electrophoresis study of Mycobacterium 
abscessus isolates previously affected by DNA degradation. J Clin Microbiol 42, 
5582-5587. 
 
 
 
 
 
 
 
 
 
  116 
 
